ANNUAL REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For
the fiscal year ended October 2,
2009
|
OR
|
¨
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Delaware
(State
or Other Jurisdiction of Incorporation or Organization)
|
75-3142681
(I.R.S.
Employer Identification No.)
|
||||
811
Hansen Way, Palo Alto, California 94303
(Address
of Principal Executive Offices and Zip Code)
|
|||||
(650)
846-2900
(Registrant’s
telephone number, including area code)
|
|||||
Securities
registered pursuant to Section 12(b) of the Act:
|
|||||
Title of each Class
|
Name of Each Exchange on Which Registered | ||||
Common
Stock, par value $0.01 per share
|
The
Nasdaq Stock Market LLC
|
||||
Securities
registered pursuant to Section 12(g) of the Act: None
|
Indicate by check mark if the
registrant is a well-known seasoned issuer, as defined in Rule 405 of the
Securities Act.
|
Yes
¨ No
x
|
||||
Indicate by check mark if the
registrant is not required to file reports pursuant to Section 13 or
Section 15(d) of the Act.
|
Yes
¨ No
x
|
||||
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
|
Yes
x No
¨
|
||||
Indicate by check mark whether the
registrant has submitted electronically and posted on its corporate Web
site, if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
|
Yes
¨ No
¨
|
||||
Indicate by check mark if
disclosure of delinquent filers pursuant to Item 405 of Regulation S-K
(§229.405 of this chapter) is not contained herein, and will not be
contained, to the best of the registrant’s knowledge, in definitive proxy
or information statements incorporated by reference in Part III of this
Form 10-K or any amendment to this Form 10-K.
|
x
|
||||
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions
of “large accelerated filer,” “accelerated filer” and “small reporting
company” in Rule 12b-2 of the Exchange Act.
|
|||||
Large
accelerated filer
|
¨
|
Accelerated
filer
|
x
|
||
Non-accelerated filer
|
¨ (Do not check if
a smaller reporting company)
|
Smaller
reporting company
|
¨
|
||
Indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the
Act).
|
Yes
¨ No
x
|
||||
The
aggregate market value of common stock held by non-affiliates of the
registrant as of April 3, 2009 (the last business day of the registrant’s
most recently completed second fiscal quarter) was approximately $69
million, based on the closing sale price of $9.50 per share of common
stock as reported on the Nasdaq Stock Market.
|
|||||
Indicate the number of shares
outstanding of each of the registrant’s classes of common stock, as of the
latest practicable date: 16,607,483 shares of the registrant’s common
stock, par value $0.01 per share, were outstanding at December
1, 2009.
|
·
|
the
transmission of radar signals for navigation and
location;
|
·
|
the
transmission of deception signals for electronic
countermeasures;
|
·
|
the
transmission, reception and amplification of voice, data and video signals
for broadcasting, data links, Internet, flight testing and other types of
commercial and military
communications;
|
·
|
providing
power and control for medical diagnostic
imaging;
|
·
|
generating
microwave energy for radiation therapy in the treatment of cancer;
and
|
·
|
generating
microwave energy for various industrial and scientific
applications.
|
·
|
Ground-based
satellite communications transmission systems use our products to enable
the transmission of microwave signals, carrying either analog or digital
information, from a ground-based station to the transponders on an
orbiting satellite by boosting the power of the low-level original signal
to desired power levels for transmission over hundreds or thousands of
miles to the satellite. The signal is received by the satellite
transponder, converted to the downlink frequency and retransmitted to a
ground-based receiving station.
The
majority of our communications products are sold into the satellite
communications market. We estimate that we have a worldwide installed base
of more than 25,000 amplifiers. We believe that we are a leading
producer of power amplifiers, amplifier subsystems and high-power
microwave devices for satellite uplinks, and that we offer one of the
industry’s most comprehensive lines of satellite communications
amplifiers, with offerings for virtually every currently applicable
frequency and power requirement for both fixed and mobile satellite
communications applications in the military and commercial arena. Our
technological expertise, our well-established worldwide service network
and our ability to design and manufacture both the fully integrated
amplifier and either the associated high-power microwave device or the
solid-state RF device allow us to provide a superior overall service to
our customers.
We
are participating in satellite communications growth areas, including:
amplifiers for the 30 gigahertz (GHz) band (Ka-band), which is one of the
major satellite communications growth areas for both commercial and
military applications; the growing application worldwide of conventional
and high-definition television for direct-to-home satellite broadcast; the
use of satellite communications for broadband data communications; and
specialized amplifiers for the military communications
market.
|
·
|
Terrestrial
broadcast systems use our products to amplify and transmit signals,
including television and radio signals at very high (“VHF”) and ultra high
(“UHF”) frequencies, or other signals at a variety of frequencies. Through
the years, we have established a customer base of several thousand
customers in the broadcast market, providing us with opportunities for
replacement, spares, upgrade and rebuilding
business.
|
·
|
Data
link communications systems use our products to transmit and receive
real-time command and control, intelligence, surveillance and
reconnaissance (“ISR”) data between airborne platforms, including UAVs and
manned airborne platforms, and their associated ground-based and
ship-based terminals via high-bandwidth digital data links. Our
products are on the airborne and ground nodes of the tactical common data
link (“TCDL”) network for various
platforms.
|
·
|
Over-the-horizon
(also referred to as “troposcatter”) systems use our high-power amplifiers
and traveling wave tubes to send a signal through the atmosphere, bouncing
the signal off the troposphere, the lowest atmospheric layer, and enabling
receipt of the signal tens of miles to hundreds of miles away. These
systems transmit voice, video and data signals without requiring the use
of a satellite, providing an easy-to-install, relocatable and
cost-efficient alternative to satellite-based
communications.
|
·
|
satellite
communications amplifier
subsystems;
|
·
|
radar
and electronic warfare subsystems;
|
·
|
specialized
antenna subsystems;
|
·
|
solid-state
integrated microwave assemblies;
|
·
|
medical
x-ray generators and control
systems;
|
·
|
modulators
and transmitters; and
|
·
|
various
electronic power supply and control equipment and
devices.
|
·
|
generate
or amplify (multiply) various forms of electromagnetic energy (these
products are generally referred to as VEDs, vacuum electron devices, or
simply as devices);
|
·
|
transmit,
direct, measure and control electromagnetic
energy;
|
·
|
provide
the voltages and currents to power and control devices that generate
electromagnetic energy; or
|
·
|
provide
some combination of the above
functions.
|
·
|
Klystrons
and gyrotrons: Klystrons are typically high-power VEDs that
operate over a narrow range of frequencies, with power output ranges from
hundreds of watts to megawatts and frequencies from 500 kilohertz (KHz) to
over 30 GHz. We produce and manufacture klystrons for a variety of radar,
communications, medical, industrial and scientific applications. Gyrotron
oscillators and amplifiers operate at very high-power and very high
frequencies. Power output of one megawatt has been achieved at frequencies
greater than 100 GHz. These devices are used in areas such as fusion
research, electronic warfare and high-resolution
radar.
|
·
|
Helix
traveling wave tubes: Helix traveling wave tubes are VEDs that
operate over a wide range of frequencies at moderate output power levels
(tens of watts to thousands of watts). These devices are ideal for
terrestrial and satellite communications and electronic warfare
applications.
|
·
|
Coupled
cavity traveling wave tubes: Coupled cavity traveling wave
tubes are VEDs that combine some of the power generating capability of a
klystron with some of the increased bandwidth (wider frequency range)
properties of a helix traveling wave tube. These amplifiers are medium
bandwidth, high-power devices, with power output levels that can be as
high as one megawatt. These devices are used primarily for high-power and
multi-function radars, including front line radar
systems.
|
·
|
Magnetrons: Magnetron
oscillators are VEDs capable of generating high-power output at relatively
low cost. Magnetrons generate power levels as high as 20 megawatts and
cover frequencies up to the 40 GHz range. We design and manufacture
magnetrons for radar, electronic warfare and missile programs within the
defense market. Shipboard platforms include search and air traffic control
radar on most aircraft carriers, cruisers and destroyers of NATO-country
naval fleets. Ground-based installations include various military and
civil search and air traffic control radar systems. We are also a supplier
of magnetrons for use in commercial weather radar. Potential new uses for
magnetrons include high-power microwave systems for disruption of enemy
electronic equipment and the disabling or destruction of roadside bombs
and other IEDs.
|
·
|
Cross-field
amplifiers: Cross-field amplifiers are VEDs used for high-power
radar applications because they have power output capability as high as
ten megawatts. Our cross-field amplifiers are primarily used to support
radar systems on the Aegis weapons used by the U.S. Navy and select
foreign naval vessels. We supply units both for new ships and for
replacements.
|
·
|
Power
grid devices: Power grid devices are lower frequency VEDs that
are used to generate, amplify and control electromagnetic energy. These
devices are used in commercial and military communications systems and
radio and television broadcasting. We also supply power grid devices for
the shortwave broadcast market. Our products are also widely used in
equipment that serves the industrial markets such as textile drying, pipe
welding and semiconductor wafer
fabrication.
|
|
In
addition to VEDs, we also sell:
|
·
|
Microwave
transmitter subsystems: Our microwave transmitter subsystems
are integrated assemblies generally built around our VED products. These
subsystems incorporate specialized high-voltage power supplies to power
the VED, plus cooling and control systems that are uniquely designed to
work in conjunction with our devices to maximize life, performance and
reliability. Microwave transmitter subsystems are used in a variety of
defense and commercial applications. Our transmitter subsystems are
available at frequencies ranging from one GHz all the way up to 100 GHz
and beyond.
|
·
|
Satellite
communications amplifiers: Satellite communications amplifiers
provide integrated power amplification for the transmission of voice,
broadcast, data, Internet and other communications signals from ground
stations to satellites in all frequency bands. We provide a broad line of
complete, integrated satellite communications amplifiers that consist of a
VED or solid-state microwave amplifier, a power supply to power the
device, radio frequency conditioning circuitry, cooling equipment,
electronics to control the amplifier and enable it to interface with the
satellite ground station, and a cabinet. These amplifiers are often
combined in sub-system configurations with other components to meet
specific customer requirements. We offer amplifiers both for defense and
for commercial applications. Our products include amplifiers based on
traveling wave tubes, klystrons, solid-state devices and millimeter-wave
devices.
|
·
|
Receiver
protectors and control components: Receiver protectors are used
in the defense market in radar systems to protect sensitive receivers from
extraneous high-power signals, thereby preventing damage to the receiver.
We have been designing and manufacturing receiver protector products for
more than 50 years. We believe that we are the world’s largest
manufacturer of receiver protectors and the only manufacturer offering the
full range of available technologies. We also manufacture a wide range of
other components used to control the RF energy in the customer’s system.
Our receiver protectors and control components are integrated into
prominent fielded military programs. As radar systems have evolved to
improve performance and reduce size and weight, we have invested in
solid-state technology to develop the microwave control components to
allow us to offer more fully integrated products, referred to as
multifunction assemblies, as required by modern radar
systems.
|
·
|
Medical
x-ray imaging systems: We design and manufacture x-ray
generators for medical imaging applications. These consist of power
supplies, cooling, control and display subsystems that drive the x-ray
equipment used by healthcare providers for medical imaging. The energy in
an x-ray imaging system is generated by an x-ray tube which is another
version of a VED operating in a different region of the electromagnetic
spectrum. These generators use the high-voltage and control systems
expertise originally developed by us while designing power systems to
drive our other VEDs. We also provide the electronics and software
subsystems that control and tie together much of the other ancillary
equipment in a typical x-ray imaging
system.
|
·
|
Antenna
systems: We design and manufacture antenna systems for a variety of
applications, including, radar, electronic warfare, communications and
telemetry. Along with a variety of antenna types, including phased array,
edge and tilt scanning antennas, conformal electronic scanning antennas,
stabilized shipboard tracking antennas and our trademark FLAPS (“Flat
Parabolic Surface”) antennas, the antenna systems also include the highly
efficient harmonic drive pedestals used to support them. The antenna
systems used on airborne, shipboard and ground-based platforms are
designed to enable high performance, high data rate transmission at
frequencies ranging from one GHz to
100GHz.
|
·
|
delay
in shipments due to various factors, including cancellations by a
customer, delays in a customer’s own production schedules, natural
disasters or manufacturing
difficulties;
|
·
|
delay
in a customer’s acceptance of a product;
or
|
·
|
a
change in a customer’s financial condition or ability to obtain
financing.
|
·
|
changes
or anticipated changes in third-party reimbursement amounts or policies
applicable to treatments using our
products;
|
·
|
revenues
becoming affected by seasonal
influences;
|
·
|
changes
in foreign currency exchange rates;
|
·
|
changes
in the relative portion of our revenues represented by our various
products;
|
·
|
timing
of the announcement, introduction and delivery of new products or product
enhancements by us and by our
competitors;
|
·
|
disruptions
in the supply or changes in the costs of raw materials, labor, product
components or transportation
services;
|
·
|
the
impact of changing levels of sales to sole purchasers of certain of our
products; and
|
·
|
the
unfavorable outcome of any
litigation.
|
·
|
terminate
existing contracts, including for the convenience of the government or
because of a default in our performance of the
contract;
|
·
|
reduce
the value of existing contracts;
|
·
|
cancel
multi-year contracts or programs;
|
·
|
audit
our contract-related costs and fees, including allocated indirect
costs;
|
·
|
suspend
or debar us from receiving new contracts pending resolution of alleged
violations of procurement laws or regulations;
and
|
·
|
control
and potentially prohibit the export of our products, technology or other
data.
|
·
|
the
need to bid on programs in advance of contract performance, which may
result in unforeseen performance issues and costs;
and
|
·
|
the
expense and delay that may arise if our competitors protest or challenge
the award made to us, which could result in a reprocurement, modified
contract, or reduced work.
|
·
|
In
order to obtain the license for the sale of such a product, we are
required to obtain information from the potential customer and provide it
to the U.S. Government. If the U.S. Government determines that the sale
presents national security risks, it may not approve the
sale.
|
·
|
Delays
caused by the requirement to obtain a required license or other
authorization may cause delays in our production, sales and export
activities, and may cause us to lose potential
sales.
|
·
|
If
we violate these laws and regulations, we could be subject to fines or
penalties, including debarment as an exporter and/or a government
contractor.
|
·
|
changes
in currency rates with respect to the U.S.
dollar;
|
·
|
changes
in regulatory requirements;
|
·
|
potentially
adverse tax consequences;
|
·
|
U.S.
and foreign government policies;
|
·
|
currency
restrictions, which may prevent the transfer of capital and profits to the
United States;
|
·
|
restrictions
imposed by the U.S. Government on the export of certain products and
technology;
|
·
|
the
responsibility of complying with multiple and potentially conflicting
laws;
|
·
|
difficulties
and costs of staffing and managing international
operations;
|
·
|
the
impact of regional or country specific business cycles and economic
instability; and
|
·
|
geopolitical
developments and conditions, including international hostilities, acts of
terrorism and governmental reactions, trade relationships and military and
political alliances.
|
·
|
difficulties
in assimilating and integrating the operations, technologies and products
acquired;
|
·
|
the
diversion of our management’s attention from other business
concerns;
|
·
|
our
operating and financial systems and controls being inadequate to deal with
our growth; and
|
·
|
the
potential loss of key employees.
|
·
|
the
jurisdictions in which profits are determined to be earned and
taxed;
|
·
|
the
resolution of issues arising from tax audits with various tax
authorities;
|
·
|
changes
in the valuation of our deferred tax assets and
liabilities;
|
·
|
adjustments
to estimated taxes upon finalization of various tax
returns;
|
·
|
increases
in expenses not deductible for tax
purposes;
|
·
|
changes
in available tax credits;
|
·
|
changes
in share-based compensation
expense;
|
·
|
changes
in tax laws, or the interpretation of such tax laws, and changes in
generally accepted accounting principles;
and/or
|
·
|
the
repatriation of non-U.S. earnings for which we have not previously
provided for U.S. taxes.
|
·
|
it
will require us to dedicate a substantial portion of our cash flow from
operations, in the near term, to make interest payments on our
indebtedness, and in the longer term, to repay the outstanding principal
amount of our indebtedness, each of which will reduce the funds available
for working capital, capital expenditures and other general corporate
expenses;
|
·
|
it
could limit our flexibility in planning for or reacting to changes in our
business, the markets in which we compete and the economy at
large;
|
·
|
it
could limit our ability to borrow additional funds in the future, if
needed, because of applicable financial and restrictive covenants of our
indebtedness; and
|
·
|
it
could make us more vulnerable to interest rate increases because a portion
of our borrowings is, and will continue to be, at variable rates of
interest.
|
·
|
incur
additional indebtedness;
|
·
|
sell
assets or consolidate or merge with or into other
companies;
|
·
|
pay
dividends or repurchase or redeem capital
stock;
|
·
|
make
certain investments;
|
·
|
issue
capital stock of our subsidiaries;
|
·
|
incur
liens; and
|
·
|
enter
into certain types of transactions with our
affiliates.
|
·
|
a
board of directors that is classified such that only one-third (33.3%) of
directors are elected each year;
|
·
|
“blank
check” preferred stock that could be issued by our board of directors to
increase the number of outstanding shares and thwart a takeover
attempt;
|
·
|
limitations
on the ability of stockholders to call special meetings of
stockholders;
|
·
|
prohibiting
stockholder action by written consent and requiring all stockholder
actions to be taken at a meeting of our
stockholders;
|
·
|
establishing
advance notice requirements for nominations for election to the board of
directors or for proposing matters that can be acted upon by stockholders
at stockholder meetings; and
|
·
|
requiring
that the affirmative vote of the holders of at least two-thirds (66.7%) of
the voting power of our issued and outstanding capital stock entitled to
vote in the election of directors be obtained to amend certain provisions
of our amended and restated certificate of
incorporation.
|
|
|
Square
Footage
|
||||||||||
Location
|
Owned
|
Leased/
Subleased
|
Segment
Using the Property
|
|||||||
Beverly,
Massachusetts
|
174,000 |
(a)
|
VED
|
|||||||
Georgetown,
Ontario, Canada
|
192,000 | 22,000 |
VED
and satcom equipment
|
|||||||
Woodland,
California
|
36,900 | 9,900 |
VED
|
|||||||
Palo
Alto, California
|
418,300 |
(b)
|
VED
and satcom equipment
|
|||||||
Mountain
View, California
|
42,500 |
VED
|
||||||||
Camarillo,
California
|
37,700 |
Other
|
||||||||
Various
other locations
|
26,000 |
(c)
|
VED
and satcom equipment
|
|||||||
(a)
|
The
Beverly, Massachusetts square footage also includes approximately 1,080
square feet leased to a tenant.
|
(b)
|
Includes
49,100 square feet that are subleased from Varian, Inc. Varian, Inc.
subleases the land from Varian Medical Systems, Inc. and Varian Medical
Systems leases the land from Stanford
University.
|
(c)
|
Leased
facilities occupied by our field sales and service
organizations.
|
Market For Registrant’s Common Equity, Related Stockholder Matters and
Issuer Purchases of Equity
Securities
|
High
|
Low
|
|||||||
Fiscal
year 2008
|
||||||||
First
fiscal quarter (September 29, 2007 to December 28, 2007)
|
$ | 20.77 | $ | 16.35 | ||||
Second
fiscal quarter (December 29, 2007 to March 28, 2008)
|
$ | 17.22 | $ | 9.09 | ||||
Third
fiscal quarter (March 29, 2008 to June 27, 2008)
|
$ | 14.00 | $ | 9.40 | ||||
Fourth
fiscal quarter (June 28, 2008 to October 3, 2008)
|
$ | 16.02 | $ | 12.13 | ||||
Fiscal
year 2009
|
||||||||
First
fiscal quarter (October 4, 2008 to January 2, 2009)
|
$ | 10.97 | $ | 5.67 | ||||
Second
fiscal quarter (January 3, 2009 to April 3, 2009)
|
$ | 9.66 | $ | 5.75 | ||||
Third
fiscal quarter (April 4, 2009 to July 3, 2009)
|
$ | 12.87 | $ | 7.80 | ||||
Fourth
fiscal quarter (July 4, 2009 to October 2, 2009)
|
$ | 12.00 | $ | 8.75 |
4/06 | 6/06 | 9/06 | 12/06 | 3/07 | 6/07 | 9/07 | 12/07 | 3/08 | 6/08 | 9/08 | 12/08 | 3/09 | 6/09 | 9/09 | ||||||||||||||||||
CPI
International, Inc
|
100.00 | 80.56 | 73.17 | 83.33 | 106.78 | 110.17 | 105.61 | 95.00 | 55.11 | 68.33 | 80.44 | 48.11 | 52.22 | 48.28 | 62.17 | |||||||||||||||||
NASDAQ
Composite
|
100.00 | 93.99 | 98.10 | 105.47 | 106.03 | 113.42 | 115.76 | 113.32 | 97.25 | 97.97 | 88.13 | 66.90 | 65.17 | 78.49 | 90.87 | |||||||||||||||||
NASDAQ
Electronic Components
|
100.00 | 88.16 | 91.00 | 92.59 | 90.29 | 103.84 | 110.84 | 107.80 | 88.55 | 93.76 | 77.05 | 54.94 | 58.28 | 67.46 | 79.55 |
FIVE-YEAR
SELECTED FINANCIAL DATA
|
||||||||||||||||||||
(in
thousands, except per share amounts)
|
||||||||||||||||||||
Year Ended | ||||||||||||||||||||
October
2,
|
October
3,
|
September 28, | September 29, |
September
30,
|
||||||||||||||||
2009
|
2008
|
2007 | 2006 | 2005 | ||||||||||||||||
Statement of Income Data:
|
||||||||||||||||||||
Sales
|
$ | 332,876 | $ | 370,014 | $ | 351,090 | $ | 339,717 | $ | 320,732 | ||||||||||
Cost
of sales(1)
|
239,385 | 261,086 | 237,789 | 236,063 | 216,031 | |||||||||||||||
Gross
profit
|
93,491 | 108,928 | 113,301 | 103,654 | 104,701 | |||||||||||||||
Research
and development
|
10,520 | 10,789 | 8,558 | 8,550 | 7,218 | |||||||||||||||
Selling
and marketing
|
19,466 | 21,144 | 19,258 | 19,827 | 18,547 | |||||||||||||||
General
and administrative
|
20,757 | 22,951 | 21,648 | 23,004 | 28,329 | |||||||||||||||
Amortization
of acquisition-related intangible assets
|
2,769 | 3,103 | 2,316 | 2,190 | 7,487 | |||||||||||||||
Total
operating costs and expenses
|
53,512 | 57,987 | 51,780 | 53,571 | 61,581 | |||||||||||||||
Operating
income
|
39,979 | 50,941 | 61,521 | 50,083 | 43,120 | |||||||||||||||
Interest
expense, net
|
16,979 | 19,055 | 20,939 | 23,806 | 20,310 | |||||||||||||||
(Gain)
loss on debt extinguishment(2)
|
(248 | ) | 633 | 6,331 | - | - | ||||||||||||||
Income
tax (benefit) expense
|
(218 | ) | 10,804 | 11,748 | 9,058 | 9,138 | ||||||||||||||
Net
income
|
$ | 23,466 | $ | 20,449 | $ | 22,503 | $ | 17,219 | $ | 13,672 | ||||||||||
Earnings
per share(3)
|
||||||||||||||||||||
Basic
|
$ | 1.44 | $ | 1.25 | $ | 1.39 | $ | 1.20 | $ | 1.05 | ||||||||||
Diluted
|
$ | 1.34 | $ | 1.16 | $ | 1.27 | $ | 1.09 | $ | 0.98 | ||||||||||
Shares
used to calculate net earnings per share(4)
|
||||||||||||||||||||
Basic
|
16,343 | 16,356 | 16,242 | 14,311 | 13,079 | |||||||||||||||
Diluted
|
17,478 | 17,697 | 17,721 | 15,789 | 13,974 | |||||||||||||||
Cash
dividend per share(5)
|
$ | - | $ | - | $ | - | $ | 1.19 | $ | 5.80 | ||||||||||
Other
Financial Data:
|
||||||||||||||||||||
EBITDA(6)
|
$ | 51,021 | $ | 61,271 | $ | 64,288 | $ | 59,096 | $ | 57,297 | ||||||||||
EBITDA
margin(7)
|
15.30 | % | 16.60 | % | 18.30 | % | 17.40 | % | 17.90 | % | ||||||||||
Operating
income margin(8)
|
12.00 | % | 13.80 | % | 17.50 | % | 14.70 | % | 13.40 | % | ||||||||||
Net
income margin(9)
|
7.00 | % | 5.50 | % | 6.40 | % | 5.10 | % | 4.30 | % | ||||||||||
Depreciation
and amortization(10)
|
$ | 10,794 | $ | 10,963 | $ | 9,098 | $ | 9,013 | $ | 14,177 | ||||||||||
Capital
expenditures(11)
|
$ | 3,365 | $ | 4,262 | $ | 8,169 | $ | 10,913 | $ | 17,131 | ||||||||||
Ratio
of earnings to fixed charges(12)
|
2.30 | x | 2.57 | x | 2.59 | x | 2.08 | x | 2.10 | x | ||||||||||
Net
cash provided by operating activities
|
$ | 30,114 | $ | 33,881 | $ | 21,659 | $ | 10,897 | $ | 31,349 | ||||||||||
Balance
Sheet Data:
|
||||||||||||||||||||
Working
capital
|
$ | 92,380 | $ | 88,103 | $ | 81,547 | $ | 77,113 | $ | 65,400 | ||||||||||
Total
assets
|
$ | 458,254 | $ | 466,948 | $ | 476,222 | $ | 441,759 | $ | 454,544 | ||||||||||
Long-term
debt
|
$ | 194,922 | $ | 224,660 | $ | 245,567 | $ | 245,067 | $ | 284,231 | ||||||||||
Total
stockholders’ equity
|
$ | 173,553 | $ | 143,865 | $ | 125,906 | $ | 99,673 | $ | 52,667 | ||||||||||
(1)
|
Includes
charges for the amortization of inventory write-up of $351 incurred in
connection with the Econco acquisition for fiscal year
2005.
|
(2)
|
The
repurchase of $8,000 of our 8% senior subordinated notes during fiscal
year 2009 resulted in a gain on debt extinguishment of $248 which was
comprised of a discount of $392, partially offset by a non-cash write-off
of $144 unamortized debt issue costs. The redemption of $10,000 of our
floating rate senior notes in fiscal year 2008 resulted in a loss on debt
extinguishment of approximately $633, including non-cash write-offs of
$420 of unamortized debt issue costs and issue discount costs and $213 in
cash payments primarily for call premiums. The debt refinancing during
fiscal year 2007 resulted in a loss on debt extinguishment of
approximately $6,331, including non-cash write-offs of $4,659 of
unamortized debt issue costs and issue discount costs and $1,953 in cash
payments for call premiums, partially offset by $281 of cash proceeds from
the early termination of the related interest rate swap
agreement.
|
(3)
|
Basic
earnings per share represents net income divided by weighted average
common shares outstanding, and diluted earnings per share represents net
income divided by weighted average common and common equivalent shares
outstanding.
|
(4)
|
On
April 7, 2006, in connection with the amendment and restatement of the
certificate of incorporation of CPI International, we effected a
3.059-to-1 stock split of the outstanding shares of common stock of CPI
International as of such date. All share and per share amounts for periods
presented herein have been retroactively restated to reflect the stock
split.
|
(5)
|
In
February 2005 and in December 2005 we paid special cash dividends of
$75,809 and $17,000, respectively, to stockholders of CPI International.
Cash dividend per share is calculated by dividing the dollar amount of the
dividend by weighted average common shares
outstanding.
|
(6)
|
EBITDA
represents earnings before net interest expense, provision for income
taxes and depreciation and amortization. For the reasons listed below, we
believe that GAAP-based financial information for leveraged businesses
such as ours should be supplemented by EBITDA so that investors better
understand our financial performance in connection with their analysis of
our business:
|
|
•
|
EBITDA
is a component of the measures used by our board of directors and
management team to evaluate our operating
performance;
|
|
•
|
our
senior credit facilities contain a covenant that requires us to maintain a
senior secured leverage ratio that contains EBITDA as a component, and our
management team uses EBITDA to monitor compliance with this covenant; see
“Management’s discussion and analysis of financial condition and results
of operations-Liquidity and Capital Resources-Covenant
compliance;”
|
|
•
|
EBITDA
is a component of the measures used by our management team to make
day-to-day operating decisions;
|
|
•
|
EBITDA
facilitates comparisons between our operating results and those of
competitors with different capital structures and therefore is a component
of the measures used by the management to facilitate internal comparisons
to competitors’ results and our industry in general;
and
|
|
•
|
the
payment of management bonuses is contingent upon, among other things, the
satisfaction by us of certain targets that contain EBITDA as a
component.
|
|
Other
companies may define EBITDA differently and, as a result, our measure of
EBITDA may not be directly comparable to EBITDA of other companies.
Although we use EBITDA as a financial measure to assess the performance of
our business, the use of EBITDA is limited because it does not include
certain material costs, such as interest and taxes, necessary to operate
our business. When analyzing our performance, EBITDA should be considered
in addition to, and not as a substitute for or superior to, net income,
cash flows from operating activities or other statements of income or
statements of cash flows data prepared in accordance with
GAAP.
|
The following table reconciles net income to
EBITDA:
|
Year Ended | ||||||||||||||||||||
October
2,
|
October
3,
|
September
28,
|
September
29,
|
September
30,
|
||||||||||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||||||||||||||
Net
income
|
$ | 23,466 | $ | 20,449 | $ | 22,503 | $ | 17,219 | $ | 13,672 | ||||||||||
Depreciation
and amortization(10)
|
10,794 | 10,963 | 9,098 | 9,013 | 14,177 | |||||||||||||||
Interest
expense, net
|
16,979 | 19,055 | 20,939 | 23,806 | 20,310 | |||||||||||||||
Income
tax (benefit) expense
|
(218 | ) | 10,804 | 11,748 | 9,058 | 9,138 | ||||||||||||||
EBITDA
|
$ | 51,021 | $ | 61,271 | $ | 64,288 | $ | 59,096 | $ | 57,297 |
(7)
|
EBITDA
margin represents EBITDA divided by
sales.
|
(8)
|
Operating
income margin represents operating income divided by
sales.
|
(9)
|
Net
income margin represents net income divided by
sales.
|
(10)
|
Depreciation
and amortization excludes amortization of deferred debt issuance costs,
which are included in interest expense,
net.
|
(11)
|
Fiscal
years 2007 and 2006 include approximately $4,100 and $2,300, respectively,
of capital expenditures for the expansion of our building in Georgetown,
Ontario, Canada. Fiscal years 2006 and 2005 include capital expenditures
of approximately $4,700 and $13,100, respectively, resulting from the
relocation of our former San Carlos, California facility to Palo Alto,
California and Mountain View,
California.
|
(12)
|
For
purposes of computing the ratio of earnings to fixed charges, earnings
consist of income from continuing operations before income taxes and fixed
charges less capitalized interest. Fixed charges consist of interest
expense, including amortization of debt issuance costs and that portion of
rental expenses that management considers to be a reasonable approximation
of interest.
|
Fiscal
Year Ended
|
||||||||||||||||||||||||
October
2, 2009
|
October
3, 2008
|
Increase
(Decrease)
|
||||||||||||||||||||||
%
of
|
%
of
|
|||||||||||||||||||||||
Amount
|
Orders
|
Amount
|
Orders
|
Amount
|
Percent
|
|||||||||||||||||||
Radar
and Electronic Warfare
|
$ | 142.2 | 40 | % | $ | 141.5 | 38 | % | $ | 0.7 | - | % | ||||||||||||
Medical
|
66.9 | 19 | 67.7 | 18 | (0.8 | ) | (1 | ) | ||||||||||||||||
Communications
|
119.2 | 33 | 127.1 | 34 | (7.9 | ) | (6 | ) | ||||||||||||||||
Industrial
|
21.2 | 6 | 24.8 | 7 | (3.6 | ) | (15 | ) | ||||||||||||||||
Scientific
|
6.5 | 2 | 13.1 | 3 | (6.6 | ) | (50 | ) | ||||||||||||||||
Total
|
$ | 356.0 | 100 | % | $ | 374.2 | 100 | % | $ | (18.2 | ) | (5 | ) % |
·
|
Radar and Electronic
Warfare: The majority of our orders in the radar and electronic
warfare markets are for products for domestic and international defense
and government end uses. Orders in these markets are characterized by many
smaller orders in the $0.5 million to $3.0 million range by product or
program, and the timing of these orders may vary from year to year. On a
combined basis, orders for the radar and electronic warfare markets were
essentially unchanged, totaling $142.2 in fiscal year 2009 as compared to
$141.5 million in fiscal year 2008. In fiscal year 2009, increases in
orders to support various domestic and foreign electronic warfare
programs, as well as the receipt of several large development orders to
support various radar programs, were partially offset by decreases in
orders for products to support certain other radar
programs.
|
·
|
Medical: Orders for our
medical products consist of orders for medical imaging applications, such
as x-ray imaging, MRI and PET applications, and for radiation therapy
applications for the treatment of cancer. The approximately 1% decrease in
medical orders from fiscal year 2008 to fiscal year 2009 was due primarily
to a decrease in demand for products to support x-ray imaging applications
due to the weakness of global economies. This decrease was partially
offset by increased demand for products to support MRI
applications.
|
·
|
Communications: Orders
for our communications products consist of orders for commercial
communications applications and military communications applications. The
approximately 6% decrease in communications orders was primarily
attributable to decreases in orders to support commercial communications
applications, including direct-to-home broadcast, satellite news gathering
and commercial radio broadcast applications. We believe that these
decreases were largely due to the weakness of global economies. These
decreases were partially offset by an increase in orders for military
communications programs, including a $13.4 million increase in orders for
the Warfighter Information Network – Tactical (“WIN-T”) program due to
order timing for that program. Military communications is a relatively new
sector of the overall communications market for us. We expect our
participation in military communications programs to continue to
grow.
|
·
|
Industrial: Orders in
the industrial market are cyclical and are generally tied to the state of
the economy. The $3.6 million decrease in industrial orders was
attributable to decreases in orders for products used in a wide variety of
industrial applications.
|
·
|
Scientific: Orders in
the scientific market are historically one-time projects and can fluctuate
significantly from period to period. The $6.6 million decrease in
scientific orders was primarily the result of the receipt of a multi-year
$5.6 million order in fiscal year 2008 for products to support a new
accelerator project for fusion research at an international scientific
institute. This order was not expected to, and did not, repeat in fiscal
year 2009; shipments for this order are scheduled to be completed in
fiscal year 2011.
|
Year Ended | ||||||||||||||||||||||||
October 2, 2009 | October 3, 2008 | September 28, 2007 | ||||||||||||||||||||||
%
of
|
%
of
|
%
of
|
||||||||||||||||||||||
Amount
|
Sales
|
Amount
|
Sales
|
Amount
|
Sales
|
|||||||||||||||||||
Sales
|
$ | 332.9 | 100.0 | % | $ | 370.0 | 100.0 | % | $ | 351.1 | 100.0 | % | ||||||||||||
Cost
of sales
|
239.4 | 71.9 | 261.1 | 70.6 | 237.8 | 67.7 | ||||||||||||||||||
Gross
profit
|
93.5 | 28.1 | 108.9 | 29.4 | 113.3 | 32.3 | ||||||||||||||||||
Research
and development
|
10.5 | 3.2 | 10.8 | 2.9 | 8.6 | 2.4 | ||||||||||||||||||
Selling
and marketing
|
19.5 | 5.9 | 21.1 | 5.7 | 19.3 | 5.5 | ||||||||||||||||||
General
and administrative
|
20.8 | 6.2 | 22.9 | 6.2 | 21.6 | 6.2 | ||||||||||||||||||
Amortization
of acquisition-related
intangibles
|
2.8 | 0.8 | 3.1 | 0.8 | 2.3 | 0.7 | ||||||||||||||||||
Operating
income
|
40.0 | 12.0 | 50.9 | 13.8 | 61.5 | 17.5 | ||||||||||||||||||
Interest
expense, net
|
17.0 | 5.1 | 19.1 | 5.2 | 20.9 | 6.0 | ||||||||||||||||||
(Gain)
loss on debt extinguishment
|
(0.2 | ) | (0.1 | ) | 0.6 | 0.2 | 6.3 | 1.8 | ||||||||||||||||
Income
before taxes
|
23.2 | 7.0 | 31.3 | 8.5 | 34.3 | 9.8 | ||||||||||||||||||
Income
tax (benefit) expense
|
(0.2 | ) | (0.1 | ) | 10.8 | 2.9 | 11.7 | 3.3 | ||||||||||||||||
Net
income
|
$ | 23.5 | 7.1 | % | $ | 20.4 | 5.5 | % | $ | 22.5 | 6.4 | % | ||||||||||||
Other
Data:
|
||||||||||||||||||||||||
EBITDA(1)
|
$ | 51.0 | 15.3 | % | $ | 61.3 | 16.6 | % | $ | 64.3 | 18.3 | % | ||||||||||||
Note: Totals
may not equal the sum of the components due to independent rounding.
Percentages are calculated based on rounded dollar amounts
presented.
|
(1)
|
EBITDA
represents earnings before net interest expense, provision for income
taxes and depreciation and amortization. For the reasons listed below, we
believe that GAAP-based financial information for leveraged businesses
such as ours should be supplemented by EBITDA so that investors better
understand our financial performance in connection with their analysis of
our business:
|
|
•
|
EBITDA
is a component of the measures used by our board of directors and
management team to evaluate our operating
performance;
|
|
•
|
our
senior credit facilities contain a covenant that requires us to maintain a
senior secured leverage ratio that contains EBITDA as a component, and our
management team uses EBITDA to monitor compliance with this
covenant;
|
|
•
|
EBITDA
is a component of the measures used by our management team to make
day-to-day operating decisions;
|
|
•
|
EBITDA
facilitates comparisons between our operating results and those of
competitors with different capital structures and, therefore, is a
component of the measures used by the management to facilitate internal
comparisons to competitors’ results and our industry in general;
and
|
|
•
|
the
payment of management bonuses is contingent upon, among other things, the
satisfaction by us of certain targets that contain EBITDA as a
component.
|
|
Other
companies may define EBITDA differently and, as a result, our measure of
EBITDA may not be directly comparable to EBITDA of other companies.
Although we use EBITDA as a financial measure to assess the performance of
our business, the use of EBITDA is limited because it does not include
certain material costs, such as interest and taxes, necessary to operate
our business. When analyzing our performance, EBITDA should be considered
in addition to, and not as a substitute for or superior to, net income,
cash flows from operating activities or other statements of income or
statements of cash flows data prepared in accordance with
GAAP.
|
|
For
a reconciliation of Net Income to EBITDA, see footnote 6 under Selected
Financial Data above.
|
Year Ended | |||||||||||||||||||||||||
October 2, 2009 | October 3, 2008 | Decrease | |||||||||||||||||||||||
%
of
|
%
of
|
||||||||||||||||||||||||
Amount
|
Sales
|
Amount
|
Sales
|
Amount
|
Percent
|
||||||||||||||||||||
Radar
and Electronic Warfare
|
$ | 135.9 | 41 | % | $ | 151.8 | 40 | % | $ | (15.9 | ) | (10 | ) % | ||||||||||||
Medical
|
61.2 | 18 | 65.8 | 18 | (4.6 | ) | (7 | ) | |||||||||||||||||
Communications
|
106.4 | 32 | 117.8 | 32 | (11.4 | ) | (10 | ) | |||||||||||||||||
Industrial
|
20.2 | 6 | 25.1 | 7 | (4.9 | ) | (20 | ) | |||||||||||||||||
Scientific
|
9.2 | 3 | 9.5 | 3 | (0.3 | ) | (3 | ) | |||||||||||||||||
Total |
|
$ | 332.9 | 100 | % | $ | 370.0 | 100 | % | $ | (37.1 | ) | (10 | ) % |
·
|
Radar and Electronic Warfare:
The majority of our sales in the radar and electronic warfare
markets are products for domestic and international defense and government
end uses. The timing of the receipt of orders and subsequent shipments in
these markets may vary from year to year. On a combined basis, sales for
these two markets decreased approximately 10% from $151.8 million in
fiscal year 2008 to $135.9 million in fiscal year 2009, primarily due to
an expected $8.7 million decrease in shipments of products to support the
Aegis weapons system and decreases in sales for several other radar and
electronic warfare programs due to the timing of order receipts for those
programs. These decreases were partially offset by the shipment of
products from development programs to support radar
applications.
|
|
Demand for our products to
support ships with the Aegis weapons system has two components: we support
new ship builds and we provide spare and repair products for previously
fielded ships. Over the past several years, we have seen high demand for
products to support a significant number of funded new ship builds for the
Aegis weapons program for U.S. and international military customers. We
have now completed supplying our products required to support these funded
new ship builds, and, as a result, we expect the near-term demand to be
primarily for spare and repair products and the near-term sales to be
roughly half of the approximately $20 million fiscal year 2008 sales
level. We expect demand for our products to increase again in several
years as the new ships are commissioned, deployed and added to the
installed base, after which they also will require spare and repair
products.
|
·
|
Medical: Sales of our
medical products consist of sales for medical imaging applications, such
as x-ray imaging, MRI and PET applications, and for radiation therapy
applications for the treatment of cancer. The 7% decrease in medical
product sales was due to decreased sales of x-ray imaging products to
international customers as a result of the weakness of global economies.
Our sales of products to support MRI and radiation therapy applications
remained stable in fiscal year
2009.
|
·
|
Communications: Sales of
our communications products consist of sales for commercial communications
applications and military communications applications. The 10% decrease in
sales in the communications market was primarily attributable to decreases
in sales to support certain commercial communications applications,
including satellite news gathering and direct-to-home broadcast
applications. We believe the decreases were largely due to the weakness of
global economies. These decreases were partially offset by an increase in
sales of products for military communications programs, which is a
relatively new sector of the overall communications market for us. We
expect our participation in military communications programs to continue
to grow.
|
·
|
Industrial: Sales in the
industrial market are cyclical and are generally tied to the state of the
economy. The $4.9 million decrease in industrial sales was attributable to
decreases in sales of products used in a wide variety of industrial
applications.
|
·
|
Scientific: Sales in the
scientific market are historically one-time projects and can fluctuate
significantly from period to period. The $0.3 million decrease in
scientific sales was primarily the result of the timing of certain
scientific programs.
|
Year Ended
|
||||||||
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Company
sponsored
|
$ | 10.5 | $ | 10.8 | ||||
Customer
sponsored, charged to cost of sales
|
17.5 | 12.0 | ||||||
$ | 28.0 | $ | 22.8 |
Year
Ended
|
|||||||||||||||||||||||||
October
3, 2008
|
September
28, 2007
|
Increase
(Decrease)
|
|||||||||||||||||||||||
%
of
|
%
of
|
||||||||||||||||||||||||
Amount
|
Sales
|
Amount
|
Sales
|
Amount
|
Percent
|
||||||||||||||||||||
Radar
and Electronic Warfare
|
$ | 151.8 | 40 | % | $ | 144.2 | 41 | % | $ | 7.6 | 5 | % | |||||||||||||
Medical
|
65.8 | 18 | 67.6 | 19 | (1.8 | ) | (3 | ) | |||||||||||||||||
Communications
|
117.8 | 32 | 112.3 | 32 | 5.5 | 5 | |||||||||||||||||||
Industrial
|
25.1 | 7 | 20.5 | 6 | 4.6 | 22 | |||||||||||||||||||
Scientific
|
9.5 | 3 | 6.5 | 2 | 3.0 | 46 | |||||||||||||||||||
Total
|
|
$ | 370.0 | 100 | % | $ | 351.1 | 100 | % | $ | 18.9 | 5 | % |
·
|
Radar and Electronic Warfare:
The majority of our sales in the radar
and electronic warfare markets are for products for domestic and
international defense and government end uses.
Approximately two-thirds of our sales in the radar and electronic
warfare markets are sales of replacements, spares and repairs. The
timing of order receipts and subsequent shipments in these markets may
vary from year to year. On a combined basis, sales for these two markets
increased approximately 5% from $144.2 million in fiscal year 2007 to
$151.8 million in fiscal year 2008. The increase in sales was due
primarily to increased sales to support the HAWK missile system, increased
sales for other radar systems and sales of radar products by our Malibu
division.
|
·
|
Medical: Sales of our medical products consist of sales
for medical imaging applications, such as x-ray imaging, PET and MRI, and
for radiation therapy applications for the treatment of cancer. The 3%
decrease in sales of our medical products was primarily due to a Russian
tender program in which we participated in fiscal years 2006 and 2007 that
did not recur in fiscal year 2008. In fiscal year 2008, sales for the
Russian tender program decreased $5.5 million in comparison to fiscal year
2007.
|
·
|
Medical: Sales of our medical products consist of sales
for medical imaging applications, such as x-ray imaging, PET and MRI, and
for radiation therapy applications for the treatment of cancer. The 3%
decrease in sales of our medical products was primarily due to a Russian
tender program in which we participated in fiscal years 2006 and 2007 that
did not recur in fiscal year 2008. In fiscal year 2008, sales for the
Russian tender program decreased $5.5 million in comparison to fiscal year
2007.
In
addition, in fiscal year 2007, a customer ordered a two-year supply of
products for MRI applications in one fiscal year, resulting in unusually
strong demand for these products, and we shipped a significant amount of
these products during that fiscal year. As a result, in fiscal year 2008,
sales of products for MRI applications decreased approximately $2.4
million.
Excluding the Russian tender program and MRI applications
from both fiscal years 2007 and 2008, medical sales increased 12% from
$53.4 million in fiscal year 2007 to $59.6 million in fiscal year
2008.
|
·
|
Communications: The 5% increase in sales in the communications
market was primarily the result of sales of telemetry and TCDL products by
our Malibu division, as well as the start of production shipments for
Increment One of the WIN-T military communications program. These
increases were partially offset by a decrease in sales of products for
certain military communications programs, including WIN-T’s predecessor
program, the now-completed Joint Network Node (“JNN”) program, and certain
broadcast network applications for which we had strong sales in fiscal
year 2007.
In
fiscal year 2008, the $7.3 million increase in sales of roducts to support
the WIN-T military communications program was offset by a $3.7 million
decrease in sales of products to support its predecessor, the JNN military
communications program, due to the completion of that program. We expect
that our overall participation levels in the WIN-T program, which ramped
up for production in the first six months of fiscal year 2008, will be
significantly higher than our participation levels in the previous JNN
program.
|
·
|
Industrial: Sales in the industrial market are cyclical.
The $4.6 million increase in industrial sales was due to sales of products
used in a wide variety of industrial applications, including induction
welding, dialectic heating and instrumentation applications and domestic
and international test
systems.
|
·
|
Scientific: Sales in the scientific market are
historically one-time projects and can fluctuate significantly from period
to period. The $3.0 million increase in scientific sales was primarily the
result of increased product shipments for the Spallation Neutron Source at
Oakridge National
Laboratory.
|
Year Ended
|
||||||||
October
3,
|
September
28,
|
|||||||
2008
|
2007
|
|||||||
Company
sponsored
|
$ | 10.8 | $ | 8.6 | ||||
Customer
sponsored, charged to cost of sales
|
$ | 12.0 | $ | 7.7 | ||||
$ | 22.8 | $ | 16.3 |
Year Ended
|
||||||||
October
3,
|
September
28,
|
|||||||
2008
|
2007
|
|||||||
Non-cash
write-off of deferred debt issue costs and
|
||||||||
issue
discount costs
|
$ | 0.4 | $ | 4.7 | ||||
Cash
payments for call premiums
|
0.2 | 1.9 | ||||||
Cash
proceeds from early termination of interest
|
||||||||
rate
swap on floating rate senior notes
|
- | (0.3 | ) | |||||
$ | 0.6 | $ | 6.3 |
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Cash
and cash equivalents
|
$ | 26.2 | $ | 28.7 | $ | 20.5 | ||||||
Working
capital
|
$ | 92.4 | $ | 88.1 | $ | 81.5 |
Year
Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
cash provided by operating activities
|
$ | 30.1 | $ | 33.9 | $ | 21.7 | ||||||
Net
cash used in investing activities
|
(3.3 | ) | (2.8 | ) | (30.4 | ) | ||||||
Net
cash used in financing activities
|
(29.3 | ) | (22.9 | ) | (1.0 | ) | ||||||
Net
(decrease) increase in cash and cash equivalents
|
$ | (2.5 | ) | $ | 8.2 | $ | (9.7 | ) |
Total
|
Less than
1 year
|
1-3 years
|
3-5 years
|
More than
5 years
|
||||||||||||||||
Operating
leases
|
$ | 6,503 | $ | 1,848 | $ | 1,315 | $ | 738 | $ | 2,602 | ||||||||||
Purchase
commitments
|
32,173 | 29,572 | 2,601 | - | - | |||||||||||||||
Debt
obligations
|
195,000 | - | 183,000 | - | 12,000 | |||||||||||||||
Interest
on debt obligations
|
32,111 | 14,017 | 16,236 | 1,603 | 255 | |||||||||||||||
Obligations
under FASB ASC 740, "Income Taxes"
|
3,630 | 3,630 | - | - | - | |||||||||||||||
Total
cash obligations
|
$ | 269,417 | $ | 49,067 | $ | 203,152 | $ | 2,341 | $ | 14,857 | ||||||||||
Standby
letters of credit
|
$ | 5,544 | $ | 5,544 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Term
loan, expiring 2014
|
$ | 66,000 | $ | 88,750 | ||||
8%
Senior subordinated notes due 2012
|
117,000 | 125,000 | ||||||
Floating
rate senior notes due 2015, net of
issue discount of $78 and $90
|
11,922 | 11,910 | ||||||
194,922 | 225,660 | |||||||
Less: Current
portion
|
- | 1,000 | ||||||
Long-term
portion
|
$ | 194,922 | $ | 224,660 | ||||
Standby
letters of credit
|
$ | 5,544 | $ | 4,609 |
Year
|
Optional
Redemption Price
|
|||
2009
|
102 | % | ||
2010
and thereafter
|
100 | % |
Year
|
Optional
Redemption Price
|
|||
2009
|
101 | % | ||
2010
and thereafter
|
100 | % |
EBITDA(a)
|
$ | 51.0 | ||
Stock
compensation expense(b)
|
2.7 | |||
Gain
on debt extinguishment(c)
|
(0.2 | ) | ||
Consolidated
EBITDA
|
$ | 53.5 |
(a)
|
For
a reconciliation of net income to EBITDA for fiscal year 2009, see
footnote 6 in “Selected Financial
Data.”
|
(b)
|
Represents
a non-cash charge for stock compensation related to stock options,
restricted stock and the discount on our employee stock
purchases.
|
(c)
|
Represents
costs associated with our debt refinancing during fiscal year 2009, which
include purchase of our 8% Notes at a discount of $0.4 million and
non-cash write-offs of $0.2 million of unamortized debt issue
costs.
|
·
|
There
is no default under the indenture.
|
·
|
The
ratio of Communications & Power Industries’ Consolidated Cash Flow (as
defined in the indenture) for the most recent four quarters to
Communications & Power Industries’ Consolidated Interest Expense (as
defined in the indenture) for the same period is at least 2:1. As of
October 2, 2009, the ratio of Communications & Power Industries’
Consolidated Cash Flow for the most recent four quarters to Communications
& Power Industries’ Consolidated Interest Expense was
3.61:1.
|
·
|
The
amount of the proposed dividend plus all previous Restricted Payments (as
defined in the indenture) does not exceed the aggregate contractual limit
on Restricted Payments, which is based on one-half of the aggregate
Consolidated Net Income of Communications & Power Industries since the
date of the issuance of the 8% Notes, the amount of certain capital
contributions and certain other items. In addition, the indenture permits
up to $10 million of additional Restricted Payments outside of the
contractual limit described in the preceding
sentence.
|
|
|
|
|
|
|
|
|
|
|
|
|
·
|
Reports
of Independent Registered Public Accounting
Firm
|
·
|
Consolidated
Balance Sheets
|
·
|
Consolidated
Statements of Income
|
·
|
Consolidated
Statements of Stockholders’ Equity and Comprehensive
Income
|
·
|
Consolidated
Statements of Cash Flows
|
·
|
Notes
to Consolidated Financial
Statements
|
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Assets
|
||||||||
Current
Assets:
|
||||||||
Cash
and cash equivalents
|
$ | 26,152 | $ | 28,670 | ||||
Restricted
cash
|
1,561 | 776 | ||||||
Accounts
receivable, net
|
45,145 | 47,348 | ||||||
Inventories
|
66,996 | 65,488 | ||||||
Deferred
tax assets
|
8,652 | 11,411 | ||||||
Prepaid
and other current assets
|
6,700 | 3,823 | ||||||
Total
current assets
|
155,206 | 157,516 | ||||||
Property,
plant, and equipment, net
|
57,912 | 62,487 | ||||||
Deferred
debt issue costs, net
|
3,609 | 4,994 | ||||||
Intangible
assets, net
|
75,430 | 78,534 | ||||||
Goodwill
|
162,225 | 162,611 | ||||||
Other
long-term assets
|
3,872 | 806 | ||||||
Total
assets
|
$ | 458,254 | $ | 466,948 | ||||
Liabilities
and stockholders’ equity
|
||||||||
Current
Liabilities:
|
||||||||
Current
portion of long-term debt
|
$ | - | $ | 1,000 | ||||
Accounts
payable
|
22,665 | 21,109 | ||||||
Accrued
expenses
|
19,015 | 23,044 | ||||||
Product
warranty
|
3,845 | 4,159 | ||||||
Income
taxes payable
|
4,305 | 7,766 | ||||||
Advance
payments from customers
|
12,996 | 12,335 | ||||||
Total
current liabilities
|
62,826 | 69,413 | ||||||
Deferred
income taxes
|
24,726 | 27,321 | ||||||
Long-term
debt, less current portion
|
194,922 | 224,660 | ||||||
Other
long-term liabilities
|
2,227 | 1,689 | ||||||
Total
liabilities
|
284,701 | 323,083 | ||||||
Commitments
and contingencies
|
||||||||
Stockholders’
equity
|
||||||||
Preferred
stock ($0.01 par value; 10,000 shares authorized
and none issued and outstanding)
|
- | - | ||||||
Common
stock ($0.01 par value, 90,000 shares authorized;
16,807 and 16,538 shares issued; 16,601
and 16,332 shares outstanding)
|
168 | 165 | ||||||
Additional
paid-in capital
|
75,630 | 71,818 | ||||||
Accumulated
other comprehensive income (loss)
|
598 | (1,809 | ) | |||||
Retained
earnings
|
99,957 | 76,491 | ||||||
Treasury
stock, at cost (206 shares)
|
(2,800 | ) | (2,800 | ) | ||||
Total
stockholders’ equity
|
173,553 | 143,865 | ||||||
Total
liabilities and stockholders' equity
|
$ | 458,254 | $ | 466,948 |
Year Ended
|
|||||||||||||
October
2,
|
October
3,
|
September
28,
|
|||||||||||
2009
|
2008
|
2007
|
|||||||||||
Sales
|
$ | 332,876 | $ | 370,014 | $ | 351,090 | |||||||
Cost
of sales
|
239,385 | 261,086 | 237,789 | ||||||||||
Gross
profit
|
93,491 | 108,928 | 113,301 | ||||||||||
Operating
costs and expenses:
|
|||||||||||||
Research and
development
|
10,520 | 10,789 | 8,558 | ||||||||||
Selling and
marketing
|
19,466 | 21,144 | 19,258 | ||||||||||
General and
administrative
|
20,757 | 22,951 | 21,648 | ||||||||||
Amortization of
acquisition-related intangible
assets
|
2,769 | 3,103 | 2,316 | ||||||||||
Total
operating costs and expenses
|
53,512 | 57,987 | 51,780 | ||||||||||
Operating
income
|
39,979 | 50,941 | 61,521 | ||||||||||
Interest
expense, net
|
16,979 | 19,055 | 20,939 | ||||||||||
(Gain)
loss on debt extinguishment
|
(248 | ) | 633 | 6,331 | |||||||||
Income
before taxes
|
23,248 | 31,253 | 34,251 | ||||||||||
Income
tax (benefit) expense
|
(218 | ) | 10,804 | 11,748 | |||||||||
Net
income
|
$ | 23,466 | $ | 20,449 | $ | 22,503 | |||||||
Earnings
per share:
|
|||||||||||||
Basic
|
$ | 1.44 | $ | 1.25 | $ | 1.39 | |||||||
Diluted
|
$ | 1.34 | $ | 1.16 | $ | 1.27 | |||||||
Shares
used to calculate earnings per share:
|
|||||||||||||
Basic
|
16,343 | 16,356 | 16,242 | ||||||||||
Diluted
|
17,478 | 17,697 | 17,721 |
Accumulated
|
|||||||||||||||||||||||||
Additional
|
Other
|
||||||||||||||||||||||||
Common Stock
|
Paid-in
|
Comprehensive
|
Retained
|
Treasury Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Capital
|
Income (Loss)
|
Earnings
|
Shares
|
Amount
|
Total
|
||||||||||||||||||
Balances,
September 29, 2006
|
16,050 | $ | 160 | $ | 65,295 | $ | 679 | $ | 33,539 | - | $ | - | $ | 99,673 | |||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||
Net
income
|
- | - | - | - | 22,503 | - | - | 22,503 | |||||||||||||||||
Unrealized
gain on cash flow hedges, net of tax expense
of $233
|
- | - | - | 431 | - | - | - | 431 | |||||||||||||||||
Total
comprehensive income
|
22,934 | ||||||||||||||||||||||||
Adoption
of SFAS No. 158, net of tax benefit of $106
|
- | - | - | (173 | ) | - | - | - | (173 | ) | |||||||||||||||
Stock-based
compensation cost
|
- | - | 1,128 | - | - | - | - | 1,128 | |||||||||||||||||
Exercise
of stock options
|
262 | 3 | 721 | - | - | - | - | 724 | |||||||||||||||||
Tax
benefit related to stock option exercises
|
- | - | 781 | - | - | - | - | 781 | |||||||||||||||||
Issuance
of common stock under employee
stock purchase plan
|
51 | 1 | 838 | - | - | - | - | 839 | |||||||||||||||||
Issuance
of restricted stock awards
|
7 | - | - | - | - | - | - | - | |||||||||||||||||
Balances,
September 28, 2007
|
16,370 | 164 | 68,763 | 937 | 56,042 | - | - | 125,906 | |||||||||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||
Net
income
|
- | - | - | - | 20,449 | - | - | 20,449 | |||||||||||||||||
Unrealized
loss on cash flow hedges, net of tax benefit
of $1,652
|
- | - | - | (2,697 | ) | - | - | - | (2 ,697 | ) | |||||||||||||||
Unrealized
actuarial loss and prior service credit for
pension liability,
|
|||||||||||||||||||||||||
net
of tax benefit of $30
|
- | - | - | (49 | ) | - | - | - | (49 | ) | |||||||||||||||
Total
comprehensive income
|
17,703 | ||||||||||||||||||||||||
Stock-based
compensation cost
|
- | - | 2,160 | - | - | - | - | 2,160 | |||||||||||||||||
Exercise
of stock options
|
9 | - | 38 | - | - | - | - | 38 | |||||||||||||||||
Tax
benefit related to stock option exercises
|
- | - | 5 | - | - | - | - | 5 | |||||||||||||||||
Issuance
of common stock under employee
stock purchase plan
|
72 | 1 | 852 | - | - | - | - | 853 | |||||||||||||||||
Issuance
of restricted stock awards
|
89 | - | - | - | - | - | - | - | |||||||||||||||||
Forfeiture
of restricted stock awards
|
(2 | ) | - | - | - | - | - | - | - | ||||||||||||||||
Purchase
of treasury stock
|
- | - | - | - | - | (206 | ) | (2,800 | ) | (2,800 | ) | ||||||||||||||
Balances,
October 3, 2008
|
16,538 | 165 | 71,818 | (1,809 | ) | 76,491 | (206 | ) | (2,800 | ) | 143,865 | ||||||||||||||
Comprehensive
income:
|
|||||||||||||||||||||||||
Net
income
|
- | - | - | - | 23,466 | - | - | 23,466 | |||||||||||||||||
Unrealized
gain on cash flow hedges, net of tax expense
of $1,471
|
- | - | - | 2,415 | - | - | - | 2,415 | |||||||||||||||||
Unrealized
actuarial loss and prior service credit for pension
liability,
|
|||||||||||||||||||||||||
net
of tax expense of $52
|
- | - | - | (8 | ) | - | - | - | (8 | ) | |||||||||||||||
Total
comprehensive income
|
25,873 | ||||||||||||||||||||||||
Stock-based
compensation cost
|
- | - | 2,729 | - | - | - | - | 2,729 | |||||||||||||||||
Exercise
of stock options
|
57 | 1 | 83 | - | - | - | - | 84 | |||||||||||||||||
Tax
benefit related to stock option exercises
|
- | - | 48 | - | - | - | - | 48 | |||||||||||||||||
Issuance
of common stock under employee
stock purchase plan
|
111 | 1 | 952 | - | - | - | - | 953 | |||||||||||||||||
Issuance
of restricted stock awards
|
106 | 1 | - | - | - | - | 1 | ||||||||||||||||||
Forfeiture
of restricted stock awards
|
(5 | ) | - | - | - | - | - | - | - | ||||||||||||||||
Balances,
October 2, 2009
|
16,807 | $ | 168 | $ | 75,630 | $ | 598 | $ | 99,957 | (206 | ) | $ | (2,800 | ) | $ | 173,553 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Cash
flows from operating activities
|
||||||||||||
Net
income
|
$ | 23,466 | $ | 20,449 | $ | 22,503 | ||||||
Adjustments
to reconcile net income to net cash
provided by operating activities:
|
||||||||||||
Depreciation
|
7,773 | 7,607 | 6,562 | |||||||||
Amortization of
intangibles
|
3,021 | 3,356 | 2,536 | |||||||||
Write-off of patent application
fees
|
83 | - | - | |||||||||
Amortization of deferred debt issue
costs
|
1,241 | 1,197 | 1,401 | |||||||||
Amortization of discount on
floating rate senior notes
|
12 | 15 | 49 | |||||||||
Non-cash loss on debt
extinguishment
|
144 | 420 | 4,659 | |||||||||
Discount on repayment of
debt
|
(392 | ) | - | - | ||||||||
Non-cash defined benefit pension
expense
|
39 | 55 | - | |||||||||
Stock-based compensation
expense
|
2,679 | 2,135 | 1,239 | |||||||||
Allowance for doubtful
accounts
|
6 | - | (329 | ) | ||||||||
Deferred income
taxes
|
(1,000 | ) | (1,360 | ) | (561 | ) | ||||||
Net
loss on the disposition of assets
|
130 | 205 | 129 | |||||||||
Tax
benefit from stock option exercises
|
212 | 50 | 1,281 | |||||||||
Excess
tax benefit on stock option exercises
|
(54 | ) | (18 | ) | (781 | ) | ||||||
Changes
in operating assets and liabilities, net
of acquired assets and assumed liabilities:
|
||||||||||||
Restricted cash
|
(785 | ) | 1,479 | (509 | ) | |||||||
Accounts receivable
|
2,197 | 5,241 | (7,388 | ) | ||||||||
Inventories
|
(1,495 | ) | 1,986 | (8,473 | ) | |||||||
Prepaid
and other current assets
|
841 | (470 | ) | (811 | ) | |||||||
Other
long-term assets
|
(3,167 | ) | (208 | ) | 476 | |||||||
Accounts payable
|
1,556 | (685 | ) | (215 | ) | |||||||
Accrued
expenses
|
(4,107 | ) | (4,953 | ) | (320 | ) | ||||||
Product
warranty
|
(314 | ) | (1,419 | ) | (653 | ) | ||||||
Income
taxes payable
|
(3,461 | ) | (779 | ) | (2,262 | ) | ||||||
Advance
payments from customers
|
661 | 203 | 2,202 | |||||||||
Other
long-term liabilities
|
828 | (625 | ) | 924 | ||||||||
Net
cash provided by operating activities
|
30,114 | 33,881 | 21,659 | |||||||||
Cash
flows from investing activities
|
||||||||||||
Capital
expenditures
|
(3,365 | ) | (4,262 | ) | (8,169 | ) | ||||||
Acquisitions, net of cash
acquired
|
- | 1,615 | (22,174 | ) | ||||||||
Payment
of patent application fees
|
- | (147 | ) | - | ||||||||
Net
cash used in investing activities
|
(3,365 | ) | (2,794 | ) | (30,343 | ) | ||||||
Cash
flows from financing activities
|
||||||||||||
Proceeds from issuance of
debt
|
- | - | 100,000 | |||||||||
Proceeds from stock purchase plan
and exercises of stock options
|
1,037 | 891 | 1,436 | |||||||||
Repayments of debt
|
(30,358 | ) | (21,000 | ) | (100,750 | ) | ||||||
Debt
issuance costs
|
- | - | (2,462 | ) | ||||||||
Purchase of treasury
stock
|
- | (2,800 | ) | - | ||||||||
Excess
tax benefit on stock option exercises
|
54 | 18 | 781 | |||||||||
Net
cash used in financing activities
|
(29,267 | ) | (22,891 | ) | (995 | ) | ||||||
Net
(decrease) increase in cash and cash equivalents
|
(2,518 | ) | 8,196 | (9,679 | ) | |||||||
Cash
and cash equivalents at beginning of year
|
28,670 | 20,474 | 30,153 | |||||||||
Cash
and cash equivalents at end of year
|
$ | 26,152 | $ | 28,670 | $ | 20,474 | ||||||
Supplemental
cash flow disclosures
|
||||||||||||
Cash
paid for interest
|
$ | 16,081 | $ | 18,720 | $ | 22,255 | ||||||
Cash
paid for income taxes, net of refunds
|
$ | 6,539 | $ | 13,099 | $ | 13,631 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
CPI
Sponsored
|
$ | 10,520 | $ | 10,789 | $ | 8,558 | ||||||
Customer
Sponsored
|
17,526 | 12,028 | 7,738 | |||||||||
$ | 28,046 | $ | 22,817 | $ | 16,296 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Weighted
average shares outstanding - Basic
|
16,343 | 16,356 | 16,242 | |||||||||
Effect
of dilutive stock options and
|
||||||||||||
nonvested restricted stock shares
and units
|
1,135 | 1,341 | 1,479 | |||||||||
Weighted
average shares outstanding - Diluted
|
17,478 | 17,697 | 17,721 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Accounts
receivable
|
$ | 45,240 | $ | 47,437 | ||||
Less:
Allowance for doubtful accounts
|
(95 | ) | (89 | ) | ||||
Accounts receivable,
net
|
$ | 45,145 | $ | 47,348 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Balance
at beginning of period
|
$ | 89 | $ | 89 | $ | 494 | ||||||
Provision
(recoveries) for doubtful accounts charged
|
||||||||||||
to general
and administrative expense
|
17 | 19 | (329 | ) | ||||||||
Write-offs
against allowance
|
(11 | ) | (19 | ) | (76 | ) | ||||||
Balance
at end of period
|
$ | 95 | $ | 89 | $ | 89 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Raw
material and parts
|
$ | 38,205 | $ | 40,187 | ||||
Work
in process
|
20,542 | 17,622 | ||||||
Finished
goods
|
8,249 | 7,679 | ||||||
$ | 66,996 | $ | 65,488 |
Year Ended
|
||||||||
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Balance
at beginning of period
|
$ | 1,928 | $ | 2,700 | ||||
Provision
for loss contracts, charged to cost of sales
|
4,173 | 2,810 | ||||||
Credit
to cost of sales upon revenue recognition
|
(2,033 | ) | (3,582 | ) | ||||
Balance
at end of period
|
$ | 4,068 | $ | 1,928 | ||||
|
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Inventories
|
$ | 3,967 | $ | 1,640 | ||||
Accrued
expenses
|
101 | 288 | ||||||
$ | 4,068 | $ | 1,928 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Land
and land leaseholds
|
$ | 4,798 | $ | 4,775 | ||||
Buildings
|
40,630 | 40,068 | ||||||
Machinery
and equipment
|
45,935 | 43,501 | ||||||
Construction
in progress
|
640 | 638 | ||||||
92,003 | 88,982 | |||||||
Less:
accumulated depreciation and amortization
|
(34,091 | ) | (26,495 | ) | ||||
Property,
plant and equipment, net
|
$ | 57,912 | $ | 62,487 |
Weighted Average
|
October 2, 2009
|
October 3, 2008
|
||||||||||||||||||||
Useful Life
(in years)
|
Cost
|
Accumulated Amortization
|
Net
|
Cost
|
Accumulated Amortization
|
Net
|
||||||||||||||||
VED
Core Technology
|
50 | $ | 30,700 | $ | (3,501 | ) | $ | 27,199 | $ | 30,700 | $ | (2,887 | ) | $ | 27,813 | |||||||
VED
Application Technology
|
25 | 19,800 | (4,505 | ) | 15,295 | 19,800 | (3,713 | ) | 16,087 | |||||||||||||
X-ray
Generator and Satcom
|
||||||||||||||||||||||
Application
Technology
|
15 | 8,000 | (3,042 | ) | 4,958 | 8,000 | (2,508 | ) | 5,492 | |||||||||||||
Antenna
and Telemetry Technology
|
25 | 5,300 | (453 | ) | 4,847 | 5,300 | (241 | ) | 5,059 | |||||||||||||
Customer
backlog
|
1 | 580 | (580 | ) | - | 580 | (580 | ) | - | |||||||||||||
Land
lease
|
46 | 11,810 | (1,434 | ) | 10,376 | 11,810 | (1,181 | ) | 10,629 | |||||||||||||
Tradename
|
20 - Indefinite
|
7,600 | (275 | ) | 7,325 | 7,600 | (55 | ) | 7,545 | |||||||||||||
Customer
list and programs
|
24 | 6,280 | (1,218 | ) | 5,062 | 6,280 | (950 | ) | 5,330 | |||||||||||||
Noncompete
agreement
|
5 | 640 | (336 | ) | 304 | 640 | (208 | ) | 432 | |||||||||||||
Patent
application fees
|
- | 64 | - | 64 | 147 | - | 147 | |||||||||||||||
$ | 90,774 | $ | (15,344 | ) | $ | 75,430 | $ | 90,857 | $ | (12,323 | ) | $ | 78,534 |
Fiscal Year
|
Amount
|
|||
2010
|
3,001 | |||
2011
|
3,001 | |||
2012
|
2,987 | |||
2013
|
2,895 | |||
2014
|
2,895 | |||
Thereafter
|
57,451 | |||
$ | 72,230 |
Reportable Segments
|
||||||||||||||||
VED
|
Satcom
|
Other
|
Total
|
|||||||||||||
Balance
at September 28, 2007
|
$ | 132,897 | $ | 13,830 | $ | 14,846 | $ | 161,573 | ||||||||
Malibu
purchase price and allocation adjustment
|
- | - | 1,028 | 1,028 | ||||||||||||
Other
adjustment
|
- | - | 10 | 10 | ||||||||||||
Balance
at October 3, 2008
|
132,897 | 13,830 | 15,884 | 162,611 | ||||||||||||
Purchase
accounting adjustment
|
(276 | ) | (110 | ) | - | (386 | ) | |||||||||
Balance
at October 2, 2009
|
$ | 132,621 | $ | 13,720 | $ | 15,884 | $ | 162,225 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Payroll
and employee benefits
|
$ | 11,015 | $ | 12,758 | ||||
Accrued
interest
|
1,786 | 2,001 | ||||||
Other
accruals
|
6,214 | 8,285 | ||||||
$ | 19,015 | $ | 23,044 |
Year Ended
|
||||||||
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Beginning
accrued warranty
|
$ | 4,159 | $ | 5,578 | ||||
Actual
costs of warranty claims
|
(4,524 | ) | (4,329 | ) | ||||
Estimates
for product warranty, charged to cost of sales
|
4,210 | 2,910 | ||||||
Ending
accrued warranty
|
$ | 3,845 | $ | 4,159 |
Level
1
|
Observable
inputs that reflect quoted prices (unadjusted) for identical assets or
liabilities in active markets.
|
Level
2
|
Inputs
reflect quoted prices for identical assets or liabilities in markets that
are not active; quoted prices for similar assets or liabilities in active
markets; inputs other than quoted prices that are observable for the asset
or the liability; or inputs that are derived principally from or
corroborated by observable market data by correlation or other
means.
|
Level
3
|
Unobservable
inputs reflecting the Company’s own assumptions incorporated in valuation
techniques used to determine fair value. These assumptions are required to
be consistent with market participant assumptions that are reasonably
available.
|
Fair
Value Measurements at Reporting Date Using
|
||||||||||||||||
Quoted
Prices in Active Markets for Identical Assets
|
Significant
Other Observable Inputs
|
Significant
Unobservable Inputs
|
||||||||||||||
Total
|
(Level
1)
|
(Level
2)
|
(Level
3)
|
|||||||||||||
Assets:
|
||||||||||||||||
Money
market and overnight U.S. Government securities1
|
$ | 22,464 | $ | 22,464 | $ | - | $ | - | ||||||||
Mutual
funds2
|
152 | 152 | - | - | ||||||||||||
Foreign
exchange forward derivatives3
|
3,467 | - | 3,467 | - | ||||||||||||
Total
assets at fair value
|
$ | 26,083 | $ | 22,616 | $ | 3,467 | - | |||||||||
Liabilities:
|
||||||||||||||||
Interest
rate swap derivative4
|
$ | 2,323 | $ | - | $ | 2,323 | $ | - | ||||||||
Total
liabilities at fair value
|
$ | 2,323 | $ | - | $ | 2,323 | $ | - |
1
The money market and overnight U.S. Government securities are
classified as part of cash and cash equivalents and restricted cash in the
consolidated balance sheet.
|
|
2
The mutual funds are classified as part of other long-term assets
in the consolidated balance sheet.
|
|
3
The foreign currency derivatives are classified as part of prepaid
and other current assets in the consolidated balance
sheet.
|
|
4
The interest rate swap derivatives are classified as part of
accrued expenses and other long-term liabilities in the consolidated
balance sheet.
|
Net
current liabilities
|
$ | (3,727 | ) | |
Property,
plant and equipment
|
719 | |||
Deferred
tax liabilities
|
(933 | ) | ||
Identifiable
intangible assets
|
8,790 | |||
Goodwill
|
15,884 | |||
$ | 20,733 |
Weighted Average Useful Life
(in years)
|
Amount
|
|||||||
Non
compete agreements
|
5 | $ | 530 | |||||
Tradename
|
Indefinite
|
1,800 | ||||||
Antenna
and Telemetry technology
|
25 | 5,300 | ||||||
Backlog
|
1 | 580 | ||||||
Customer
relationships
|
15 | 580 | ||||||
$ | 8,790 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Term
loan, expiring 2014
|
$ | 66,000 | $ | 88,750 | ||||
8%
Senior subordinated notes due 2012
|
117,000 | 125,000 | ||||||
Floating
rate senior notes due 2015, net of
issue discount of $78 and $90
|
11,922 | 11,910 | ||||||
194,922 | 225,660 | |||||||
Less: Current
portion
|
- | 1,000 | ||||||
Long-term
portion
|
$ | 194,922 | $ | 224,660 | ||||
Standby
letters of credit
|
$ | 5,544 | $ | 4,609 |
Year
|
Optional
Redemption Price
|
|||
2009
|
102 | % | ||
2010
and thereafter
|
100 | % |
Year
|
Optional
Redemption Price
|
|||
2009
|
101 | % | ||
2010
and thereafter
|
100 | % |
Fiscal Year
|
Term
Loan
|
8% Senior
Subordinated Notes
|
Floating Rate
Senior Notes
|
Total
|
||||||||||||
2010
|
$ | - | $ | - | $ | - | $ | - | ||||||||
2011
|
66,000 | - | - | 66,000 | ||||||||||||
2012
|
- | 117,000 | - | 117,000 | ||||||||||||
2013
|
- | - | - | - | ||||||||||||
2014
|
- | - | - | - | ||||||||||||
Thereafter
|
- | - | 12,000 | 12,000 | ||||||||||||
$ | 66,000 | $ | 117,000 | $ | 12,000 | $ | 195,000 |
Asset
Derivatives
|
Liability
Derivatives
|
||||||||||
Balance
Sheet Location
|
Fair
Value
|
Balance
Sheet Location
|
Fair
Value
|
||||||||
Derivatives
designated as hedging instruments
|
|||||||||||
Interest
rate contracts
|
Prepaid
and other current assets
|
$ | - |
Accrued
expenses
|
$ | (1,766 | ) | ||||
Interest
rate contracts
|
Other
long-term assets
|
- |
Other
long-term liabilities
|
(557 | ) | ||||||
Forward
contracts
|
Prepaid
and other current assets
|
3,467 |
Accrued
expenses
|
- | |||||||
Total
derivatives designated as hedging instruments
|
$ | 3,467 | $ | (2,323 | ) |
Derivatives
in Cash Flow Hedging Relationships
|
Amount
of
Loss
Recognized
in
OCI on Derivative
(Effective
Portion)
|
Location
of
Loss
Reclassified from Accumulated
OCI
into Income
(Effective
Portion)
|
Amount
of
Loss
Reclassified from Accumulated OCI into Income (Effective
Portion)
|
Location
of
Loss
Recognized in
Income
on Derivative
(Ineffective
and Excluded Portion)
|
Amount
of Loss Recognized in Income on Derivative (Ineffective and Excluded
Portion )
|
||||||||||
Interest
rate contracts
|
$ | (2,173 | ) |
Interest
expense, net
|
$ | (1,797 | ) |
Interest
expense, net
|
$ | (51 | ) | ||||
Forward
contracts
|
(315 | ) |
Cost
of sales
|
(3,963 | ) |
General
and administrative
|
(321 | )(a) | |||||||
Forward
contracts
|
Research
and development
|
(192 | ) | ||||||||||||
Forward
contracts
|
Selling
and marketing
|
(106 | ) | ||||||||||||
Forward
contracts
|
General
and administrative
|
(317 | ) | ||||||||||||
Total
|
$ | (2,488 | ) | $ | (6,375 | ) | $ | (372 | ) | ||||||
(a) |
The
amount of loss recognized in income represents a $323 loss related to the
amount excluded from the assessment of hedge effectiveness, net of a $2
gain related to the ineffective portion of the hedging
relationships.
|
Fiscal
Year
|
Operating
Leases
|
|||
2010
|
$ | 1,848 | ||
2011
|
749 | |||
2012
|
566 | |||
2013
|
421 | |||
2014
|
317 | |||
Thereafter
|
2,602 | |||
$ | 6,503 |
Fiscal
Year
|
Purchase
Contracts
|
|||
2010
|
$ | 29,572 | ||
2011
|
2,427 | |||
2012
|
174 | |||
2013
|
- | |||
2014
|
- | |||
$ | 32,173 |
Number of Shares
|
Weighted-Average Price
|
Weighted-Average Remaining Contractual Term
(Years)
|
Aggregate Intrinsic Value
|
|||||||||||||
Vested
|
2,845,996 | $ | 4.73 | 4.4 | $ | 20,227 | ||||||||||
Expected
to vest
|
520,664 | 15.10 | 7.7 | 131 | ||||||||||||
Total
|
3,366,660 | 6.34 | 4.9 | $ | 20,358 |
Oustanding Options
|
Exercisable Options
|
||||||||||||||||||||||||
Number of Shares
|
Weighted-Average Exercise
Price
|
Weighted-Average Remaining Contractual Term
(Years)
|
Aggregate Intrinsic Value
|
Number of Shares
|
Weighted-Average Exercise
Price
|
Weighted-Average Remaining Contractual Term
(Years)
|
Aggregate Intrinsic Value
|
||||||||||||||||||
Balance
at September 29, 2006
|
3,163,057 | $ | 4.51 | 7.24 | $ | 28,799 | 2,345,833 | $ | 2.85 | 6.90 | $ | 24,199 | |||||||||||||
Granted
|
316,500 | 14.71 | |||||||||||||||||||||||
Exercised
|
(262,123 | ) | 2.76 | ||||||||||||||||||||||
Forfeited
or cancelled
|
(46,353 | ) | 9.19 | ||||||||||||||||||||||
Balance
at September 28, 2007
|
3,171,081 | $ | 5.61 | 6.58 | $ | 42,513 | 2,259,528 | $ | 3.00 | 5.98 | $ | 36,184 | |||||||||||||
Granted
|
208,750 | 16.79 | |||||||||||||||||||||||
Exercised
|
(8,906 | ) | 4.32 | ||||||||||||||||||||||
Forfeited
or cancelled
|
(21,631 | ) | 17.75 | ||||||||||||||||||||||
Balance
at October 3, 2008
|
3,349,294 | $ | 6.23 | 5.77 | $ | 24,363 | 2,556,762 | $ | 3.83 | 5.16 | $ | 23,052 | |||||||||||||
Granted
|
108,000 | 10.00 | |||||||||||||||||||||||
Exercised
|
(57,382 | ) | 1.44 | ||||||||||||||||||||||
Forfeited
or cancelled
|
(17,149 | ) | 16.85 | ||||||||||||||||||||||
Balance
at October 2, 2009
|
3,382,763 | $ | 6.38 | 4.95 | $ | 20,362 | 2,845,996 | $ | 4.73 | 4.43 | $ | 20,227 |
Options Outstanding
|
Exercisable Options
|
||||||||||||||
Exercise
Price
|
Number of Options
Outstanding
|
Weighted-Average Remaining Contractual Term
(Years)
|
Number of Options
Exercisable
|
Weighted-Average Remaining Contractual Term
(Years)
|
|||||||||||
$ | 0.20 | 619,109 | 3.4 | 619,109 | 3.4 | ||||||||||
$ | 0.74 | 120,743 | 1.0 | 120,743 | 1.0 | ||||||||||
$ | 1.08 | 8,000 | 4.3 | 8,000 | 4.3 | ||||||||||
$ | 4.32 | 1,689,223 | 4.5 | 1,689,223 | 4.5 | ||||||||||
$ | 6.61 | 49,032 | 5.0 | 49,032 | 5.0 | ||||||||||
$ | 6.98 | 23,706 | 5.5 | 23,706 | 5.5 | ||||||||||
$ | 10.00 | 108,000 | 9.2 | - | - | ||||||||||
$ | 14.22 | 279,500 | 7.2 | 140,750 | 7.2 | ||||||||||
$ | 16.79 | 195,950 | 8.2 | 49,558 | 8.2 | ||||||||||
$ | 16.94 | 1,500 | 8.2 | 375 | 8.2 | ||||||||||
$ | 17.09 | 6,000 | 7.4 | 4,000 | 7.4 | ||||||||||
$ | 18.00 | 271,000 | 6.6 | 139,500 | 6.6 | ||||||||||
$ | 19.53 | 7,000 | 8.0 | - | - | ||||||||||
$ | 19.80 | 4,000 | 7.6 | 2,000 | 7.6 | ||||||||||
Total
|
3,382,763 | 5.0 | 2,845,996 | 4.4 |
Number of Shares
|
Weighted-Average Grant-Date Fair Value Per
Share
|
Aggregate Fair Value*
|
||||||||||
Nonvested
at September 29, 2006
|
9,999 | $ | 18.00 | |||||||||
Granted
|
7,022 | $ | 17.09 | |||||||||
Vested
|
(5,555 | ) | $ | 18.00 | $ | 97 | ||||||
Forfeited
|
- | $ | - | |||||||||
Nonvested
at September 28, 2007
|
11,466 | $ | 17.44 | |||||||||
Granted
|
114,461 | $ | 15.22 | |||||||||
Vested
|
(5,848 | ) | $ | 17.60 | $ | 62 | ||||||
Forfeited
|
(2,925 | ) | 16.79 | |||||||||
Nonvested
at October 3, 2008
|
117,154 | $ | 15.28 | |||||||||
Granted
|
142,721 | $ | 8.87 | |||||||||
Vested
|
(36,377 | ) | $ | 14.81 | $ | 233 | ||||||
Forfeited
|
(5,200 | ) | $ | 10.85 | ||||||||
Nonvested
at October 2, 2009
|
218,298 | $ | 11.27 |
*
Based on the value of the Company's stock on the date that the restricted
stock units vest.
|
Year Ended
|
||||||||
October
3,
|
September
28,
|
|||||||
2008
|
2007
|
|||||||
Expected
term (in years)
|
6.25 | 6.25 | ||||||
Expected
volatility
|
41.20 | % | 49.33 | % | ||||
Dividend
yield
|
0.0 | % | 0.0 | % | ||||
Risk-free
rate
|
3.8 | % | 4.7 | % |
Contractual
term (in years)
|
10.00 | |||
Expected
volatility
|
51.50 | % | ||
Risk-free
rate
|
3.5 | % | ||
Dividend
yield
|
0 | % |
Expected
volatility
|
51.50 | % | ||
Risk-free
rate
|
3.5 | % | ||
Dividend
yield
|
0 | % |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Share-based
compensation cost recognized in the statement
of income by caption:
|
||||||||||||
Cost of
sales
|
$ | 506 | $ | 425 | $ | 274 | ||||||
Research and
development
|
174 | 153 | 94 | |||||||||
Selling and
marketing
|
262 | 229 | 122 | |||||||||
General and
administrative
|
1,737 | 1,328 | 749 | |||||||||
$ | 2,679 | $ | 2,135 | $ | 1,239 | |||||||
Share-based
compensation cost capitalized in inventory
|
$ | 516 | $ | 453 | $ | 297 | ||||||
Share-based
compensation cost remaining in inventory at
end of period
|
$ | 86 | $ | 76 | $ | 48 | ||||||
Share-based
compensation expense by type of award:
|
||||||||||||
Stock
options
|
$ | 1,746 | $ | 1,544 | $ | 1,006 | ||||||
Restricted stock
and restricted stock units
|
804 | 438 | 110 | |||||||||
Stock purchase
plan
|
129 | 153 | 123 | |||||||||
$ | 2,679 | $ | 2,135 | $ | 1,239 |
Year
Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
U.S.
|
$ | 15,206 | $ | 20,405 | $ | 20,466 | ||||||
Foreign
|
8,042 | 10,848 | 13,785 | |||||||||
$ | 23,248 | $ | 31,253 | $ | 34,251 |
Year
Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Current
|
||||||||||||
Federal
|
$ | 1,263 | $ | 6,904 | $ | 4,946 | ||||||
State
|
1,083 | 1,980 | 2,320 | |||||||||
Foreign
|
(1,201 | ) | 3,035 | 4,693 | ||||||||
1,145 | 11,919 | 11,959 | ||||||||||
Deferred
|
||||||||||||
Federal
|
(99 | ) | (934 | ) | 117 | |||||||
State
|
(738 | ) | (208 | ) | (143 | ) | ||||||
Foreign
|
(526 | ) | 27 | (185 | ) | |||||||
(1,363 | ) | (1,115 | ) | (211 | ) | |||||||
Income
tax expense
|
$ | (218 | ) | $ | 10,804 | $ | 11,748 |
Year
Ended
|
||||||||||||
October
2,
2009
|
October
3,
2008
|
September
28,
2007
|
||||||||||
Statutory
federal income tax rate
|
35.0 | % | 35.0 | % | 35.0 | % | ||||||
Domestic
manufacturing deduction
|
(1.7 | ) | (1.5 | ) | (0.7 | ) | ||||||
Foreign
tax rate differential
|
(2.8 | ) | (2.3 | ) | (1.8 | ) | ||||||
State
taxes
|
4.3 | 3.7 | 3.8 | |||||||||
Research
and development credit
|
(1.3 | ) | - | - | ||||||||
Change
in foreign filing position
|
- | - | (5.3 | ) | ||||||||
Tax
contingency reserve (reversal)/accrual
|
(14.6 | ) | 0.5 | 0.1 | ||||||||
Correction
of error from prior year
|
(7.2 | ) | (1.4 | ) | 2.6 | |||||||
New
state legislation
|
(2.9 | ) | - | - | ||||||||
Tax
treaty benefits
|
(12.1 | ) | - | - | ||||||||
Other
differences
|
2.4 | 0.6 | 0.6 | |||||||||
Effective
tax rate
|
(0.9 | ) % | 34.6 | % | 34.3 | % |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Deferred
tax assets:
|
||||||||
Inventory
and other reserves
|
$ | 7,121 | $ | 6,347 | ||||
Accrued
vacation
|
1,607 | 2,120 | ||||||
Deferred
compensation and other accruals
|
5,338 | 4,263 | ||||||
Other comprehensive
income
|
- | 1,102 | ||||||
Debt issuance
costs
|
525 | 684 | ||||||
Foreign
jurisdictions
|
1,974 | 558 | ||||||
Land lease
amortization
|
654 | 663 | ||||||
State
taxes
|
158 | 521 | ||||||
Gross deferred tax
assets
|
17,377 | 16,258 | ||||||
Valuation
allowance
|
- | - | ||||||
Total
deferred tax assets
|
$ | 17,377 | $ | 16,258 | ||||
Deferred
tax liabilities:
|
||||||||
Accelerated
depreciation
|
$ | (6,475 | ) | $ | (7,491 | ) | ||
Acquisition-related
intangibles
|
(23,659 | ) | (23,450 | ) | ||||
Other comprehensive
income
|
(432 | ) | - | |||||
Foreign
jurisdictions
|
(2,885 | ) | (1,091 | ) | ||||
Total
deferred tax liabilities
|
$ | (33,451 | ) | $ | (32,032 | ) | ||
Net
deferred tax liabilities
|
$ | (16,074 | ) | $ | (15,774 | ) |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Current
deferred tax assets
|
$ | 8,652 | $ | 11,411 | ||||
Long-term
deferred tax assets (other long-term assets)
|
- | 136 | ||||||
Long-term
deferred tax liabilities
|
(24,726 | ) | (27,321 | ) | ||||
Net
deferred tax liabilities
|
$ | (16,074 | ) | $ | (15,774 | ) |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Income
taxes payable
|
$ | 2,713 | $ | 5,609 | ||||
Other
long-term liabilities
|
615 | - | ||||||
$ | 3,328 | $ | 5,609 |
Year
Ended
|
|||||||
October
2,
|
October
3,
|
||||||
2009
|
2008
|
||||||
Unrecognized
tax benefits - beginning of year
|
$ | 5,609 | $ | 4,954 | |||
Settlements
and effective settlements with tax authorities and related
remeasurements
|
(75 | ) | - | ||||
Increase
in balances related to tax positions taken in current year
|
228 | 1,183 | |||||
Decrease
in balances related to tax positions taken in prior years
|
(2,964 | ) | - | ||||
Increase
in balances related to tax positions taken in prior years
|
512 | (235 | ) | ||||
Changes
due to translation of foreign currency
|
18 | (293 | ) | ||||
Unrecognized
tax benefits - end of year
|
$ | 3,328 | $ | 5,609 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Sales
from external customers
|
||||||||||||
VED
|
$ | 246,717 | $ | 279,364 | $ | 280,010 | ||||||
Satcom
equipment
|
69,534 | 74,264 | 67,965 | |||||||||
Other
|
16,625 | 16,386 | 3,115 | |||||||||
$ | 332,876 | $ | 370,014 | $ | 351,090 | |||||||
Intersegment
product transfers
|
||||||||||||
VED
|
$ | 18,070 | $ | 27,462 | $ | 22,898 | ||||||
Satcom
equipment
|
9 | 116 | 23 | |||||||||
$ | 18,079 | $ | 27,578 | $ | 22,921 | |||||||
Capital
expenditures
|
||||||||||||
VED
|
$ | 2,536 | $ | 2,659 | $ | 7,649 | ||||||
Satcom
equipment
|
141 | 692 | 341 | |||||||||
Other
|
688 | 911 | 179 | |||||||||
$ | 3,365 | $ | 4,262 | $ | 8,169 | |||||||
EBITDA
|
||||||||||||
VED
|
$ | 54,791 | $ | 69,923 | $ | 75,230 | ||||||
Satcom
equipment
|
5,598 | 5,997 | 6,056 | |||||||||
Other
|
(9,368 | ) | (14,649 | ) | (16,998 | ) | ||||||
$ | 51,021 | $ | 61,271 | $ | 64,288 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
Total
assets
|
||||||||
VED
|
$ | 324,490 | $ | 324,483 | ||||
Satcom
equipment
|
46,720 | 48,219 | ||||||
Other
|
87,044 | 94,246 | ||||||
$ | 458,254 | $ | 466,948 |
|
·
|
EBITDA
is a component of the measures used by the Company’s board of directors
and management team to evaluate the Company’s operating
performance;
|
|
·
|
the
Senior Credit Facilities contain a covenant that requires the Company to
maintain a senior secured leverage ratio that contains EBITDA as a
component, and the Company’s management team uses EBITDA to monitor
compliance with this covenant;
|
|
·
|
EBITDA
is a component of the measures used by the Company’s management team to
make day-to-day operating
decisions;
|
|
·
|
EBITDA
facilitates comparisons between the Company’s operating results and those
of competitors with different capital structures and, therefore, is a
component of the measures used by the Company’s management to facilitate
internal comparisons to competitors’ results and the Company’s industry in
general; and
|
|
·
|
the
payment of management bonuses is contingent upon, among other things, the
satisfaction by the Company of certain targets that contain EBITDA as a
component.
|
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Operating
income
|
||||||||||||
VED
|
$ | 49,006 | $ | 64,431 | $ | 70,938 | ||||||
Satcom
equipment
|
4,861 | 5,327 | 5,551 | |||||||||
Other
|
(13,888 | ) | (18,817 | ) | (14,968 | ) | ||||||
$ | 39,979 | $ | 50,941 | $ | 61,521 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
Net
income
|
$ | 23,466 | $ | 20,449 | $ | 22,503 | ||||||
Depreciation
and amortization
|
10,794 | 10,963 | 9,098 | |||||||||
Interest
expense, net
|
16,979 | 19,055 | 20,939 | |||||||||
Income
tax (benefit) expense
|
(218 | ) | 10,804 | 11,748 | ||||||||
EBITDA
|
$ | 51,021 | $ | 61,271 | $ | 64,288 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
United
States
|
$ | 45,028 | $ | 48,593 | ||||
Canada
|
12,831 | 13,843 | ||||||
Other
|
53 | 51 | ||||||
Total
|
$ | 57,912 | $ | 62,487 |
October
2,
|
October
3,
|
|||||||
2009
|
2008
|
|||||||
United
States
|
$ | 114,252 | $ | 114,297 | ||||
Canada
|
47,973 | 48,314 | ||||||
$ | 162,225 | $ | 162,611 |
Year Ended
|
||||||||||||
October
2,
|
October
3,
|
September
28,
|
||||||||||
2009
|
2008
|
2007
|
||||||||||
United
States
|
$ | 210,590 | $ | 237,909 | $ | 208,682 | ||||||
All
foreign countries
|
122,286 | 132,105 | 142,408 | |||||||||
Total
sales
|
$ | 332,876 | $ | 370,014 | $ | 351,090 |
First
|
Second
|
Third
|
Fourth
|
|||||||||||||
Quarter
|
Quarter
|
Quarter
|
Quarter
|
|||||||||||||
Year
ended October 2, 2009
|
||||||||||||||||
Sales
|
$ | 77,146 | $ | 81,903 | $ | 82,520 | $ | 91,307 | ||||||||
Gross
profit
|
19,916 | 21,766 | 24,284 | 27,525 | ||||||||||||
Net
income
|
7,655 | 3,689 | 3,870 | 8,252 | ||||||||||||
Basic
earnings per share
|
$ | 0.47 | $ | 0.23 | $ | 0.24 | $ | 0.50 | ||||||||
Diluted
earnings per share
|
$ | 0.44 | $ | 0.21 | $ | 0.22 | $ | 0.47 | ||||||||
Year
ended October 3, 2008
|
||||||||||||||||
Sales
|
$ | 85,910 | $ | 94,804 | $ | 90,734 | $ | 98,566 | ||||||||
Gross
profit
|
24,136 | 28,066 | 27,232 | 29,494 | ||||||||||||
Net
income
|
2,510 | 6,154 | 5,824 | 5,961 | ||||||||||||
Basic
earnings per share
|
$ | 0.15 | $ | 0.38 | $ | 0.36 | $ | 0.37 | ||||||||
Diluted
earnings per share
|
$ | 0.14 | $ | 0.35 | $ | 0.33 | $ | 0.34 |
CONDENSED CONSOLIDATING BALANCE SHEET | ||||||||||||||||||||||||
As of October 2, 2009 | ||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Assets
|
||||||||||||||||||||||||
Cash
and cash equivalents
|
$ | 10 | $ | 15,055 | $ | 759 | $ | 10,328 | $ | - | $ | 26,152 | ||||||||||||
Restricted
cash
|
- | - | 1,467 | 94 | - | 1,561 | ||||||||||||||||||
Accounts
receivable, net
|
- | 18,456 | 12,581 | 14,108 | - | 45,145 | ||||||||||||||||||
Inventories
|
- | 41,877 | 7,622 | 18,117 | (620 | ) | 66,996 | |||||||||||||||||
Deferred
tax assets
|
- | 8,494 | 2 | 156 | - | 8,652 | ||||||||||||||||||
Intercompany
receivable
|
- | 9,033 | 6,751 | 10,534 | (26,318 | ) | - | |||||||||||||||||
Prepaid
and other current assets
|
- | 5,396 | 475 | 829 | - | 6,700 | ||||||||||||||||||
Total
current assets
|
10 | 98,311 | 29,657 | 54,166 | (26,938 | ) | 155,206 | |||||||||||||||||
Property,
plant and equipment, net
|
- | 42,048 | 3,001 | 12,863 | - | 57,912 | ||||||||||||||||||
Deferred
debt issue costs, net
|
344 | 3,265 | - | - | - | 3,609 | ||||||||||||||||||
Intangible
assets, net
|
- | 54,891 | 13,477 | 7,062 | - | 75,430 | ||||||||||||||||||
Goodwill
|
- | 93,307 | 20,973 | 47,945 | - | 162,225 | ||||||||||||||||||
Other
long-term assets
|
- | 3,645 | 227 | - | - | 3,872 | ||||||||||||||||||
Intercompany
notes receivable
|
- | 1,035 | - | - | (1,035 | ) | - | |||||||||||||||||
Investment
in subsidiaries
|
211,575 | 114,416 | - | - | (325,991 | ) | - | |||||||||||||||||
Total
assets
|
$ | 211,929 | $ | 410,918 | $ | 67,335 | $ | 122,036 | $ | (353,964 | ) | $ | 458,254 | |||||||||||
Liabilities
and stockholders' equity
|
||||||||||||||||||||||||
Accounts
payable
|
$ | (1 | ) | $ | 11,100 | $ | 2,730 | $ | 8,836 | $ | - | $ | 22,665 | |||||||||||
Accrued
expenses
|
137 | 13,293 | 1,634 | 3,951 | - | 19,015 | ||||||||||||||||||
Product
warranty
|
- | 1,893 | 452 | 1,500 | - | 3,845 | ||||||||||||||||||
Income
taxes payable
|
- | 1,683 | 151 | 2,471 | - | 4,305 | ||||||||||||||||||
Advance
payments from customers
|
- | 7,389 | 4,368 | 1,239 | - | 12,996 | ||||||||||||||||||
Intercompany
payable
|
26,318 | - | - | - | (26,318 | ) | - | |||||||||||||||||
Total
current liabilities
|
26,454 | 35,358 | 9,335 | 17,997 | (26,318 | ) | 62,826 | |||||||||||||||||
Deferred
income taxes
|
- | 20,342 | - | 4,384 | - | 24,726 | ||||||||||||||||||
Intercompany
notes payable
|
- | - | - | 1,035 | (1,035 | ) | - | |||||||||||||||||
Long-term
debt, less current portion
|
11,922 | 183,000 | - | - | - | 194,922 | ||||||||||||||||||
Other
long-term liabilities
|
- | 1,720 | 36 | 471 | - | 2,227 | ||||||||||||||||||
Total
liabilities
|
38,376 | 240,420 | 9,371 | 23,887 | (27,353 | ) | 284,701 | |||||||||||||||||
Common
stock
|
168 | - | - | - | - | 168 | ||||||||||||||||||
Parent
investment
|
- | 52,241 | 43,167 | 58,615 | (154,023 | ) | - | |||||||||||||||||
Additional
paid-in capital
|
75,630 | - | - | (211 | ) | 211 | 75,630 | |||||||||||||||||
Accumulated
other comprehensive gain (loss)
|
598 | 598 | - | (223 | ) | (375 | ) | 598 | ||||||||||||||||
Retained
earnings
|
99,957 | 117,659 | 14,797 | 39,968 | (172,424 | ) | 99,957 | |||||||||||||||||
Treasury
stock
|
(2,800 | ) | - | - | - | - | (2,800 | ) | ||||||||||||||||
Total
stockholders’ equity
|
173,553 | 170,498 | 57,964 | 98,149 | (326,611 | ) | 173,553 | |||||||||||||||||
Total
liabilities and stockholders' equity
|
$ | 211,929 | $ | 410,918 | $ | 67,335 | $ | 122,036 | $ | (353,964 | ) | $ | 458,254 |
CONDENSED
CONSOLIDATING BALANCE SHEET
|
||||||||||||||||||||||||
As
of October 3, 2008
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Assets
|
||||||||||||||||||||||||
Cash
and cash equivalents
|
$ | 84 | $ | 26,272 | $ | 493 | $ | 1,821 | $ | - | $ | 28,670 | ||||||||||||
Restricted
cash
|
- | - | 629 | 147 | - | 776 | ||||||||||||||||||
Accounts
receivable, net
|
- | 22,453 | 12,353 | 12,542 | - | 47,348 | ||||||||||||||||||
Inventories
|
- | 42,066 | 6,759 | 17,653 | (990 | ) | 65,488 | |||||||||||||||||
Deferred
tax assets
|
- | 10,853 | 2 | 556 | - | 11,411 | ||||||||||||||||||
Intercompany
receivable
|
- | 8,523 | 5,135 | 13,454 | (27,112 | ) | - | |||||||||||||||||
Prepaid
and other current assets
|
- | 2,370 | 632 | 821 | - | 3,823 | ||||||||||||||||||
Total
current assets
|
84 | 112,537 | 26,003 | 46,994 | (28,102 | ) | 157,516 | |||||||||||||||||
Property,
plant and equipment, net
|
- | 45,556 | 3,047 | 13,884 | - | 62,487 | ||||||||||||||||||
Deferred
debt issue costs, net
|
392 | 4,602 | - | - | - | 4,994 | ||||||||||||||||||
Intangible
assets, net
|
- | 56,700 | 14,168 | 7,666 | - | 78,534 | ||||||||||||||||||
Goodwill
|
- | 93,375 | 20,973 | 48,263 | - | 162,611 | ||||||||||||||||||
Other
long-term assets
|
- | 383 | 287 | 136 | - | 806 | ||||||||||||||||||
Intercompany
notes receivable
|
- | 1,035 | - | - | (1,035 | ) | - | |||||||||||||||||
Investment
in subsidiaries
|
182,869 | 101,193 | - | - | (284,062 | ) | - | |||||||||||||||||
Total
assets
|
$ | 183,345 | $ | 415,381 | $ | 64,478 | $ | 116,943 | $ | (313,199 | ) | $ | 466,948 | |||||||||||
Liabilities
and stockholders' equity
|
||||||||||||||||||||||||
Current
portion of long-term debt
|
$ | - | $ | 1,000 | $ | - | $ | - | $ | - | $ | 1,000 | ||||||||||||
Accounts
payable
|
272 | 10,893 | 2,116 | 7,828 | - | 21,109 | ||||||||||||||||||
Accrued
expenses
|
186 | 14,905 | 3,143 | 4,810 | - | 23,044 | ||||||||||||||||||
Product
warranty
|
- | 2,002 | 538 | 1,619 | - | 4,159 | ||||||||||||||||||
Income
taxes payable
|
- | 1,280 | 213 | 6,273 | - | 7,766 | ||||||||||||||||||
Advance
payments from customers
|
- | 7,624 | 3,132 | 1,579 | - | 12,335 | ||||||||||||||||||
Intercompany
payable
|
27,112 | - | - | - | (27,112 | ) | - | |||||||||||||||||
Total
current liabilities
|
27,570 | 37,704 | 9,142 | 22,109 | (27,112 | ) | 69,413 | |||||||||||||||||
Deferred
income taxes
|
- | 21,922 | - | 5,399 | - | 27,321 | ||||||||||||||||||
Intercompany
notes payable
|
- | - | - | 1,035 | (1,035 | ) | - | |||||||||||||||||
Long-term
debt, less current portion
|
11,910 | 212,750 | - | - | - | 224,660 | ||||||||||||||||||
Other
long-term liabilities
|
- | 1,213 | - | 476 | - | 1,689 | ||||||||||||||||||
Total
liabilities
|
39,480 | 273,589 | 9,142 | 29,019 | (28,147 | ) | 323,083 | |||||||||||||||||
Common
stock
|
165 | - | - | - | - | 165 | ||||||||||||||||||
Parent
investment
|
- | 50,020 | 43,167 | 58,114 | (151,301 | ) | - | |||||||||||||||||
Additional
paid-in capital
|
71,818 | - | - | - | - | 71,818 | ||||||||||||||||||
Accumulated
other comprehensive loss
|
(1,809 | ) | (1,809 | ) | - | (283 | ) | 2,092 | (1,809 | ) | ||||||||||||||
Retained
earnings
|
76,491 | 93,581 | 12,169 | 30,093 | (135,843 | ) | 76,491 | |||||||||||||||||
Treasury
stock
|
(2,800 | ) | - | - | - | - | (2,800 | ) | ||||||||||||||||
Total
stockholders’ equity
|
143,865 | 141,792 | 55,336 | 87,924 | (285,052 | ) | 143,865 | |||||||||||||||||
Total
liabilities and stockholders' equity
|
$ | 183,345 | $ | 415,381 | $ | 64,478 | $ | 116,943 | $ | (313,199 | ) | $ | 466,948 |
CONDENSED
CONSOLIDATING STATEMENT OF INCOME
|
||||||||||||||||||||||||
For
the Year Ended October 2, 2009
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Sales
|
$ | - | $ | 209,545 | $ | 75,161 | $ | 128,105 | $ | (79,935 | ) | $ | 332,876 | |||||||||||
Cost
of sales
|
- | 155,137 | 63,087 | 101,466 | (80,305 | ) | 239,385 | |||||||||||||||||
Gross
profit
|
- | 54,408 | 12,074 | 26,639 | 370 | 93,491 | ||||||||||||||||||
Operating
costs and expenses:
|
||||||||||||||||||||||||
Research
and development
|
- | 3,323 | 8 | 7,189 | - | 10,520 | ||||||||||||||||||
Selling
and marketing
|
- | 7,246 | 4,342 | 7,878 | - | 19,466 | ||||||||||||||||||
General
and administrative
|
- | 13,957 | 3,797 | 3,003 | - | 20,757 | ||||||||||||||||||
Amortization of acquisition-related intangible assets
|
- | 1,558 | 607 | 604 | - | 2,769 | ||||||||||||||||||
Total
operating costs and expenses
|
- | 26,084 | 8,754 | 18,674 | - | 53,512 | ||||||||||||||||||
Operating
income
|
- | 28,324 | 3,320 | 7,965 | 370 | 39,979 | ||||||||||||||||||
Interest
expense (income), net
|
987 | 15,920 | (9 | ) | 81 | - | 16,979 | |||||||||||||||||
Gain
on debt extinguishment
|
- | (248 | ) | - | - | - | (248 | ) | ||||||||||||||||
(Loss)
income before income tax expense
|
||||||||||||||||||||||||
and
equity in income of subsidiaries
|
(987 | ) | 12,652 | 3,329 | 7,884 | 370 | 23,248 | |||||||||||||||||
Income
tax (benefit) expense
|
(375 | ) | 1,447 | 701 | (1,991 | ) | - | (218 | ) | |||||||||||||||
Equity
in income of subsidiaries
|
24,078 | 12,873 | - | - | (36,951 | ) | - | |||||||||||||||||
Net
income
|
$ | 23,466 | $ | 24,078 | $ | 2,628 | $ | 9,875 | $ | (36,581 | ) | $ | 23,466 |
CONDENSED
CONSOLIDATING STATEMENT OF INCOME
|
||||||||||||||||||||||||
For
the Year Ended October 3, 2008
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Sales
|
$ | - | $ | 228,215 | $ | 81,065 | $ | 140,420 | $ | (79,686 | ) | $ | 370,014 | |||||||||||
Cost
of sales
|
- | 163,032 | 69,153 | 108,275 | (79,374 | ) | 261,086 | |||||||||||||||||
Gross
profit
|
- | 65,183 | 11,912 | 32,145 | (312 | ) | 108,928 | |||||||||||||||||
Operating
costs and expenses:
|
||||||||||||||||||||||||
Research
and development
|
- | 3,108 | 444 | 7,237 | - | 10,789 | ||||||||||||||||||
Selling
and marketing
|
- | 7,724 | 4,494 | 8,926 | - | 21,144 | ||||||||||||||||||
General
and administrative
|
- | 14,572 | 4,180 | 4,199 | - | 22,951 | ||||||||||||||||||
Amortization of acquisition-related intangible assets
|
- | 1,391 | 1,108 | 604 | - | 3,103 | ||||||||||||||||||
Total
operating costs and expenses
|
- | 26,795 | 10,226 | 20,966 | - | 57,987 | ||||||||||||||||||
Operating
income
|
- | 38,388 | 1,686 | 11,179 | (312 | ) | 50,941 | |||||||||||||||||
Interest
expense (income), net
|
1,734 | 17,355 | (53 | ) | 19 | - | 19,055 | |||||||||||||||||
Loss
on debt extinguishment
|
633 | - | - | - | - | 633 | ||||||||||||||||||
(Loss)
income before income tax expense
|
||||||||||||||||||||||||
and
equity in income of subsidiaries
|
(2,367 | ) | 21,033 | 1,739 | 11,160 | (312 | ) | 31,253 | ||||||||||||||||
Income
tax (benefit) expense
|
(900 | ) | 8,689 | 186 | 2,829 | - | 10,804 | |||||||||||||||||
Equity
in income of subsidiaries
|
21,916 | 9,572 | - | - | (31,488 | ) | - | |||||||||||||||||
Net
income
|
$ | 20,449 | $ | 21,916 |
|
$ | 1,553 |
|
$ | 8,331 |
|
$ | (31,800 | ) |
|
$ | 20,449 |
CONDENSED
CONSOLIDATING STATEMENT OF INCOME
|
||||||||||||||||||||||||
For
the Year Ended September 28, 2007
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Sales
|
$ | - | $ | 221,150 | $ | 64,375 | $ | 140,808 | $ | (75,243 | ) | $ | 351,090 | |||||||||||
Cost
of sales
|
- | 151,825 | 53,419 | 108,493 | (75,948 | ) | 237,789 | |||||||||||||||||
Gross
profit
|
- | 69,325 | 10,956 | 32,315 | 705 | 113,301 | ||||||||||||||||||
Operating
costs and expenses:
|
||||||||||||||||||||||||
Research
and development
|
- | 2,729 | 95 | 5,734 | - | 8,558 | ||||||||||||||||||
Selling
and marketing
|
- | 7,958 | 3,398 | 7,902 | - | 19,258 | ||||||||||||||||||
General
and administrative
|
- | 14,871 | 1,644 | 5,133 | - | 21,648 | ||||||||||||||||||
Amortization of acquisition-related intangible assets
|
- | 1,462 | 250 | 604 | - | 2,316 | ||||||||||||||||||
Total
operating costs and expenses
|
- | 27,020 | 5,387 | 19,373 | - | 51,780 | ||||||||||||||||||
Operating
income
|
- | 42,305 | 5,569 | 12,942 | 705 | 61,521 | ||||||||||||||||||
Interest
expense (income), net
|
7,301 | 13,833 | (57 | ) | (138 | ) | - | 20,939 | ||||||||||||||||
Loss
on debt extinguishment
|
4,279 | 2,052 | - | - | - | 6,331 | ||||||||||||||||||
(Loss)
income before income tax expense
|
||||||||||||||||||||||||
and
equity in income of subsidiaries
|
(11,580 | ) | 26,420 | 5,626 | 13,080 | 705 | 34,251 | |||||||||||||||||
Income
tax (benefit) expense
|
(4,390 | ) | 11,630 | 323 | 4,185 | - | 11,748 | |||||||||||||||||
Equity
in income of subsidiaries
|
29,693 | 14,903 | - | - | (44,596 | ) | - | |||||||||||||||||
Net
income
|
$ | 22,503 | $ | 29,693 | $ | 5,303 | $ | 8,895 | $ | (43,891 | ) | $ | 22,503 |
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
|
||||||||||||||||||||||||
For
the Year Ended October 2, 2009
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash
flows from operating activities
|
||||||||||||||||||||||||
Net
cash (used in) provided by operating activities
|
$ | (1,867 | ) | $ | 30,502 | $ | 624 | $ | 855 | $ | - | $ | 30,114 | |||||||||||
Cash
flows from investing activities
|
||||||||||||||||||||||||
Capital
expenditures
|
- | (2,870 | ) | (358 | ) | (137 | ) | - | (3,365 | ) | ||||||||||||||
Net
cash used in investing activities
|
- | (2,870 | ) | (358 | ) | (137 | ) | - | (3,365 | ) | ||||||||||||||
Cash
flows from financing activities
|
||||||||||||||||||||||||
Proceeds
from stock purchase plan and exercises of stock options
|
1,037 | - | - | - | - | 1,037 | ||||||||||||||||||
Repayments
of debt
|
- | (30,358 | ) | - | - | - | (30,358 | ) | ||||||||||||||||
Intercompany
dividends / debt
|
756 | (8,545 | ) | - | 7,789 | - | - | |||||||||||||||||
Excess
tax benefit on stock option exercises
|
- | 54 | - | - | - | 54 | ||||||||||||||||||
Net
cash provided by (used in) financing activities
|
1,793 | (38,849 | ) | - | 7,789 | - | (29,267 | ) | ||||||||||||||||
Net
(decrease) increase in cash and cash equivalents
|
(74 | ) | (11,217 | ) | 266 | 8,507 | - | (2,518 | ) | |||||||||||||||
Cash
and cash equivalents at beginning of year
|
84 | 26,272 | 493 | 1,821 | - | 28,670 | ||||||||||||||||||
Cash
and cash equivalents at end of year
|
$ | 10 | $ | 15,055 | $ | 759 | $ | 10,328 | $ | - | $ | 26,152 |
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
|
||||||||||||||||||||||||
For
the Year Ended October 3, 2008
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash
flows from operating activities
|
||||||||||||||||||||||||
Net
cash (used in) provided by operating activities
|
$ | (2,985 | ) | $ | 26,023 | $ | (78 | ) | $ | 10,921 | $ | - | $ | 33,881 | ||||||||||
Cash
flows from investing activities
|
||||||||||||||||||||||||
Capital
expenditures
|
- | (3,302 | ) | (240 | ) | (720 | ) | - | (4,262 | ) | ||||||||||||||
Acquisitions,
net of cash acquired
|
- | 1,615 | - | - | - | 1,615 | ||||||||||||||||||
Payment
of patent application fees
|
- | - | (147 | ) | - | - | (147 | ) | ||||||||||||||||
Net
cash used in investing activities
|
- | (1,687 | ) | (387 | ) | (720 | ) | - | (2,794 | ) | ||||||||||||||
Cash
flows from financing activities
|
||||||||||||||||||||||||
Proceeds
from stock purchase plan and exercises of stock options
|
891 | - | - | - | - | 891 | ||||||||||||||||||
Repayments
of debt
|
(10,000 | ) | (11,000 | ) | - | - | - | (21,000 | ) | |||||||||||||||
Purchase
of treasury stock
|
(2,800 | ) | - | - | - | - | (2,800 | ) | ||||||||||||||||
Intercompany
dividends / debt
|
13,600 | (3,600 | ) | - | (10,000 | ) | - | - | ||||||||||||||||
Excess
tax benefit on stock option exercises
|
- | 18 | - | - | - | 18 | ||||||||||||||||||
Net
cash provided by (used in) financing activities
|
1,691 | (14,582 | ) | - | (10,000 | ) | - | (22,891 | ) | |||||||||||||||
Net
(decrease) increase in cash and cash equivalents
|
(1,294 | ) | 9,754 | (465 | ) | 201 | - | 8,196 | ||||||||||||||||
Cash
and cash equivalents at beginning of year
|
1,378 | 16,518 | 958 | 1,620 | - | 20,474 | ||||||||||||||||||
Cash
and cash equivalents at end of year
|
$ | 84 | $ | 26,272 | $ | 493 | $ | 1,821 | $ | - | $ | 28,670 |
CONDENSED
CONSOLIDATING STATEMENT OF CASH FLOWS
|
||||||||||||||||||||||||
For
the Year Ended September 28, 2007
|
||||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
|
Non-Guarantor
|
Consolidating
|
Consolidated
|
|||||||||||||||||||
(CPI
Int'l)
|
(CPI)
|
Subsidiaries
|
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash
flows from operating activities
|
||||||||||||||||||||||||
Net
cash (used in) provided by operating activities
|
$ | (8,497 | ) | $ | 24,520 | $ | 710 | $ | 4,926 | $ | - | $ | 21,659 | |||||||||||
Cash
flows from investing activities
|
||||||||||||||||||||||||
Capital
expenditures
|
- | (3,396 | ) | (42 | ) | (4,731 | ) | - | (8,169 | ) | ||||||||||||||
Acquisitions,
net of cash acquired
|
- | (22,174 | ) | - | - | - | (22,174 | ) | ||||||||||||||||
Net
cash used in investing activities
|
- | (25,570 | ) | (42 | ) | (4,731 | ) | - | (30,343 | ) | ||||||||||||||
Cash
flows from financing activities
|
||||||||||||||||||||||||
Proceeds
from issuance of debt
|
- | 100,000 | - | - | - | 100,000 | ||||||||||||||||||
Proceeds
from stock purchase plan and exercises of stock options
|
1,436 | - | - | - | - | 1,436 | ||||||||||||||||||
Repayments
of debt
|
(58,000 | ) | (42,750 | ) | - | - | - | (100,750 | ) | |||||||||||||||
Debt
issuance costs
|
- | (2,462 | ) | - | - | - | (2,462 | ) | ||||||||||||||||
Intercompany
dividends
|
66,300 | (66,300 | ) | - | - | - | - | |||||||||||||||||
Excess
tax benefit on stock option exercises
|
- | 781 | - | - | - | 781 | ||||||||||||||||||
Net
cash provided by (used in) financing activities
|
9,736 | (10,731 | ) | - | - | - | (995 | ) | ||||||||||||||||
Net
increase (decrease) in cash and cash equivalents
|
1,239 | (11,781 | ) | 668 | 195 | - | (9,679 | ) | ||||||||||||||||
Cash
and cash equivalents at beginning of year
|
139 | 28,299 | 290 | 1,425 | - | 30,153 | ||||||||||||||||||
Cash
and cash equivalents at end of year
|
$ | 1,378 | $ | 16,518 | $ | 958 | $ | 1,620 | $ | - | $ | 20,474 |
CPI International, Inc. | |||
By:
|
/s/ O.
JOE CALDARELLI
|
|
|
O. Joe
Caldarelli
Chief Executive
Officer
|
|||
Date: December 10, 2009 | |||
By: | /s/ JOEL A. LITTMAN | ||
Joel A.
Littman
Chief Financial
Officer, Treasurer and Secretary
(Principal
Financial and Accounting Officer)
|
|||
Date: December 10, 2009 |
Signature
|
Title
|
Date
|
||||
/s/ O. JOE CALDARELLI
|
Chief
Executive Officer and Director
|
December
10, 2009
|
||||
O.
Joe Caldarelli |
(Principal Executive Officer) | |||||
/s/ JOEL A. LITTMAN | Chief Financial Officer, Treasurer | December 10, 2009 | ||||
Joel
A. Littman
|
and
Secretary (Principal Financial
and
Accounting Officer)
|
|||||
MICHAEL TARGOFF*
|
Chairman
of the Board of Directors
|
December
10, 2009
|
||||
Michael
Targoff
|
||||||
MICHAEL F. FINLEY*
|
Director
|
December
10, 2009
|
||||
Michael
F. Finley
|
||||||
JEFFREY P. HUGHES*
|
Director
|
December
10, 2009
|
||||
Jeffrey
P. Hughes
|
||||||
STEPHEN R. LARSON*
|
Director
|
December
10, 2009
|
||||
Stephen
R. Larson
|
||||||
WILLIAM P. RUTLEDGE*
|
Director
|
December
10, 2009
|
||||
William
P. Rutledge
|
*By: | /s/ JOEL A. LITTMAN | ||||||
Joel
A. Littman
Attorney-in-fact
|
Exhibit Number |
Exhibit
Description
|
2.1
|
Stock
Sale Agreement (“Stock Sale Agreement”), dated as of June 9, 1995, by and
between Communications & Power Industries, Inc. (“CPI”) (as successor
by merger to CPII Acquisition Corp., then known as Communications &
Power Industries Holding Corporation) and Varian Associates, Inc. (“Varian
Associates”) (Exhibit 2.1)(1)
|
||
2.2
|
First
Amendment to Stock Sale Agreement, dated as of August 11, 1995, by and
among Holding, CPI (as successor by merger to CPII Acquisition) and Varian
Associates (Exhibit 2.2)(1)
|
||
2.3
|
Second
Amendment to Stock Sale Agreement, dated as of August 11, 1995, by and
among Holding, CPI (as successor by merger to CPII Acquisition) and Varian
Associates (Exhibit 2.3)(1)
|
||
2.4 |
Modification
Agreement to Stock Sale Agreement, dated June 18, 2004, by and between CPI
and Varian Medical Systems, Inc. (Exhibit 10.2)(9)
|
||
3.1 |
Restated
Certificate of Incorporation of CPI, filed with the Delaware Secretary of
State on December 10, 2004 (Exhibit 3.1)(10)
|
||
3.2 |
Amended
and Restated Bylaws of CPI, dated March 19, 2002 (Exhibit
3.2)(4)
|
||
3.3 |
Amended
and Restated Certificate of Incorporation of the Registrant, filed with
the Delaware Secretary of State on April 7, 2006 (Exhibit
3.3)(15)
|
||
3.4 |
Amended
and Restated Bylaws of the Registrant, effective April 7, 2006 (Exhibit
3.4) (15)
|
||
4.1
|
Indenture,
dated as of January 23, 2004, by and among CPI, as Issuer, the Guarantors
named therein, as Guarantors, and The Bank of New York Trust Company, N.A.
(as successor to BNY Western Trust Company), as Trustee (Exhibit
4.1)(7)
|
||
4.2
|
Amended
and Restated Management Stockholders Agreement, dated as of April 27,
2006, by and among the Registrant, Cypress Merchant Banking Partners II
L.P., Cypress Merchant B II C.V., 55th Street Partners II L.P., Cypress
Side-by-Side LLC, and certain management stockholders named therein
(Exhibit 4.1)(16)
|
||
4.3 |
Indenture,
dated as of February 22, 2005, by and between the Registrant, as Issuer,
and The Bank of New York Trust Company, N.A., as Trustee (Exhibit
10.2)(11)
|
||
4.4
|
Amended
and Restated Registration Rights Agreement, dated as of April 27, 2006, by
and among CPI International, Inc., Cypress Merchant Banking Partners II
L.P., Cypress Merchant B II C.V., 55th Street Partners II L.P. and Cypress
Side-by-Side LLC (Exhibit 4.1)(16)
|
||
4.5 | Specimen common stock certificate of the Registrant (Exhibit 4.5)(15) |
Exhibit
Number
|
Exhibit
Description
|
10.1
|
Credit
Agreement (“Credit Agreement”), dated as of January 23, 2004, amended and
restated as of November 29, 2004, by and among CPI, as Borrower, the
Guarantors named therein, the Lenders from time to time party thereto, UBS
Securities LLC, Bear, Stearns & Co. Inc., UBS Loan Finance LLC, UBS
AG, Stamford Branch, Bear Stearns Corporate Lending Inc., Wachovia Bank,
National Association, and Wachovia Capital Markets, LLC (Exhibit
10.1)(10)
|
||
10.2 |
Amendment
No. 1, dated as of February 16, 2005, to the Credit Agreement (Exhibit
10.1)(11)
|
||
10.3 |
Amendment
No. 2, dated as of April 13, 2005, to the Credit Agreement (Exhibit
10.1)(13)
|
||
10.4 |
Amendment
No. 3, dated as of December 15, 2005, to the Credit Agreement (Exhibit
10.1)(14)
|
||
10.5 |
Security
Agreement, dated as of January 23, 2004, among CPI, the Guarantors party
thereto, and UBS AG, Stamford Branch (Exhibit 10.2)(7)
|
||
10.6 |
Cross
License Agreement, dated as of August 10, 1995, between CPI and Varian
Associates (Exhibit 10.11)(1)
|
||
10.7
|
Agreement
of Purchase and Sale (San Carlos Property), dated February 7, 2003, by and
between CPI (as successor to Holding) and Palo Alto Medical Foundation;
Seventh Amendment, dated November 12, 2003; and Ninth Amendment, dated
June 16, 2004 (Exhibit 10.1)(9)
|
||
10.8
|
Agreement
re: Environmental Matters, dated June 18, 2004, by and between 301 Holding
LLC, CPI, Varian Medical Systems, Inc. and Palo Alto Medical Foundation
(Exhibit 10.3)(9)
|
||
10.9
|
Assignment
and Assumption of Lessee’s Interest in Lease (Units 1-4, Palo Alto) and
Covenants, Conditions and Restrictions on Leasehold Interests (Units 1-12,
Palo Alto), dated as of August 10, 1995, by and among Varian Realty Inc.,
Varian Associates and CPI (Exhibit 10.13)(1)
|
||
10.10 |
Fourth
Amendment of Lease, dated December 15, 2000, by and between The Board of
Trustees of the Leland Stanford Junior University and CPI (Exhibit
10.10)(3)
|
||
10.11 |
Sublease
(Unit 8, Palo Alto), dated as of August 10, 1995, by and between Varian
Realty Inc. and CPI (Exhibit 10.15)(1)
|
||
10.12
|
Sublease
(Building 4, Palo Alto), dated as of August 10, 1995, by and between CPI,
as Sublessee, Varian, as Sublessor, and Varian Realty Inc., as Adjacent
Property Sublessor (Exhibit 10.16)(1)
|
||
10.13
|
First Amendment to Sublease, Subordination, Non-Disturbance and Attornment Agreement, dated as of April 2, 1999, by and among Varian, Inc., CPI, Varian, and Varian Realty Inc. (Exhibit 10.15)(12) |
Exhibit
Number
|
Exhibit
Description
|
10.14 |
Second
Amendment to Sublease, dated as of April 28, 2000, by and between Varian,
Inc. and CPI (Exhibit 10.16) (12)
|
||
10.15 |
Communications
& Power Industries 2000 Stock Option Plan (Exhibit
10.32)(2)
|
||
10.16 |
First
Amendment to Communications and Power Industries 2000 Stock Option Plan
(Exhibit 10.32.1)(5)
|
||
10.17 |
Form
of Stock Option Agreement 2000 Stock Option Plan (Exhibit
10.33)(2)
|
||
10.18 |
Form
of Option Rollover Agreement (U.S. Employees) (Exhibit
10.3)(7)
|
||
10.19 |
Form
of Option Rollover Agreement (Canadian Employees) (Exhibit
10.5)(12)
|
||
10.20 |
Conformed
copy of 2004 Stock Incentive Plan reflecting amendments adopted on
September 24, 2004 and December 7, 2006 (Exhibit
10.20)(17)
|
||
10.21 |
Form
of Option Agreement (Employees) under the 2004 Stock Incentive Plan
(Exhibit 10.2)(8)
|
||
10.22 |
Form
of Option Agreement (Directors) under the 2004 Stock Incentive Plan
(Exhibit 10.3)(8)
|
||
10.23
|
Conformed
copy of 2006 Equity and Performance Incentive Plan reflecting amendments
adopted on December 7, 2006, December 9, 2008 and February 24, 2009
(Exhibit 10.1)(24)
|
||
10.24 |
Form
of Stock Option Agreement (IPO Grant) under 2006 Equity and Performance
Incentive Plan (Exhibit 10.25)(15)
|
||
10.25 |
Form
of Stock Option Agreement (Senior Executives) (IPO Grant) under 2006
Equity and Performance Incentive Plan (Exhibit
10.26)(15)
|
||
10.26 |
Form
of Stock Option Agreement (Directors) under 2006 Equity and Performance
Incentive Plan (Exhibit 10.27)(15)
|
||
10.27 |
Form
of Restricted Stock Agreement (Directors) under 2006 Equity and
Performance Incentive Plan (Exhibit 10.28)(15)
|
||
10.28 |
Conformed
copy of 2006 Employee Stock Purchase Plan reflecting amendments adopted on
July 1, 2006 and December 7, 2006 (Exhibit 10.28)(17)
|
||
10.29 |
Pension
Plan for Executive Employees of CPI Canada, Inc. (as applicable to O. Joe
Caldarelli) effective January 1, 2002 (Exhibit
10.43)(6)
|
||
10.30 |
First
Amendment and Restatement of the CPI Non-Qualified Deferred Compensation
Plan effective as of December 1, 2004 (Exhibit
10.3)(22)
|
||
10.31
|
Employment
Agreement, dated as of April 27, 2006, by and between Communications &
Power Industries Canada Inc. and O. Joe Caldarelli (Exhibit
10.1)(16)
|
Exhibit
Number
|
Exhibit
Description
|
10.32 |
Amended
and Restated Employment Agreement, dated as of January 17, 2008, by and
between CPI and Robert A. Fickett (Exhibit 10.1)(22)
|
||
10.33 |
Amended
and Restated Employment Agreement, dated as of January 17, 2008, by and
between CPI and Joel A. Littman (Exhibit 10.2)(22)
|
||
10.34 |
Employment
Agreement, dated November 2, 2002, by and between CPI and Don Coleman
(Exhibit 10.41)(6)
|
||
10.35 |
Form
of Indemnification Agreement (Exhibit 10.36)(15)
|
||
10.36 |
Form
of Stock Option Agreement (Senior Executives) under 2006 Equity and
Performance Incentive Plan (Exhibit 10.1)(18)
|
||
10.37 |
Form
of Stock Option Agreement under 2006 Equity and Performance Incentive Plan
(Exhibit 10.2)(18)
|
||
10.38
|
Employment
Agreement, dated June 27, 2000, by and between CPI and John R. Beighley
(Exhibit 10.1)(19)
|
||
10.39
|
Amended
and Restated Credit Agreement, dated as of August 1, 2007, among CPI,
as Borrower, the Guarantors named therein, the Lenders from time to time
party thereto, UBS Securities LLC and Bear, Stearns & Co. Inc., UBS
Loan Finance LLC, UBS AG, Stamford Branch, , Bear Stearns Corporate
Lending Inc., The Royal Bank of Scotland PLC, and RBS Securities Corp
(Exhibit 10.1)(20)
|
||
10.40 |
Form
of Restricted Stock Agreement (Senior Executives) under 2006 Equity and
Performance Incentive Plan (Exhibit 10.1)(21)
|
||
10.41 |
Form
of Restricted Stock Agreement under 2006 Equity and Performance Incentive
Plan (Exhibit 10.2)(21)
|
||
10.42 |
Form
of Restricted Stock Unit Award Agreement (Senior Executives) under 2006
Equity and Performance Incentive Plan (Exhibit
10.3)(21)
|
||
10.43 |
Form
of Restricted Stock Unit Award Agreement under 2006 Equity and Performance
Incentive Plan (Exhibit 10.4)(21)
|
||
10.44 |
Employment
Agreement, dated June 21, 2004, by and between CPI and Andrew Tafler
(Exhibit 10.44)(23)
|
||
10.45 |
New
Form of Performance Stock Option Agreement (Senior Executives) under 2006
Equity and Performance Incentive Plan (Exhibit
10.45)(23)
|
||
10.46 |
New
Form of Performance Stock Option Agreement under 2006 Equity and
Performance Incentive Plan (Exhibit 10.46)(23)
|
||
10.47 | New Form of Performance Restricted Stock Agreement (Senior Executives) under 2006 Equity and Performance Incentive Plan (Exhibit 10.47)(23) |
Exhibit
Number
|
Exhibit
Description
|
10.48 |
New
Form of Performance Restricted Stock Agreement under 2006 Equity and
Performance Incentive Plan (Exhibit 10.48)(23)
|
||
10.49 |
New
Form of Performance Restricted Stock Unit Award Agreement (Senior
Executives) under 2006 Equity and Performance Incentive Plan (Exhibit
10.49)(23)
|
||
10.50 |
New
Form of Performance Restricted Stock Unit Award Agreement under 2006
Equity and Performance Incentive Plan (Exhibit
10.50)(23)
|
||
21 |
Subsidiaries
of the Registrant
|
||
23.1 |
Consent
of KPMG LLP
|
||
24 |
Powers
of Attorney of the Board of Directors and Officers
|
||
31.1 |
Certification
of Chief Executive Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e),
promulgated under the Securities Exchange Act of 1934, as
amended
|
||
31.2 |
Certification
of Chief Financial Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e),
promulgated under the Securities Exchange Act of 1934, as
amended
|
||
32.1 |
Certifications
of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
||
32.2 |
Certifications
of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
(1) |
Incorporated
by reference to Communications & Power Industries Inc.’s Registration
Statement on Form S-1 (Registration No. 033-96858) filed on September 12,
1995
|
(2) |
Incorporated
by reference to Communications & Power Industries Inc.’s Annual Report
on Form 10-K for the fiscal year ended September 29, 2000 (File No.
033-96858)
|
(3) |
Incorporated
by reference to Communications & Power Industries Inc.’s Quarterly
Report on Form 10-Q for the quarter ended December 29, 2000 (File No.
033-96858)
|
(4) |
Incorporated
by reference to Communications & Power Industries Inc.’s Quarterly
Report on Form 10-Q for the quarter ended March 29,
2002
|
(5) |
Incorporated
by reference to Communications & Power Industries Inc.’s Quarterly
Report on Form 10-Q for the quarter ended April 4,
2003
|
(6) |
Incorporated
by reference to Communications & Power Industries Inc.’s Annual Report
on Form 10-K for the fiscal year ended October 3,
2003
|
(7) |
Incorporated
by reference to Communications & Power Industries Inc.’s Quarterly
Report on Form 10-Q for the quarter ended January 2,
2004
|
(8) |
Incorporated
by reference to the Registrant’s Quarterly Report on Form 10-Q for the
quarter ended April 2,
2004
|
(9) |
Incorporated
by reference to the Registrant’s Quarterly Report on Form 10-Q for the
quarter ended July 2, 2004
|
(10) |
Incorporated
by reference to the Registrant’s Annual Report on Form 10-K for the fiscal
year ended October 1, 2004
|
(11) |
Incorporated
by reference to the Registrant’s Form 8-K filed on February 23,
2005
|
(12) |
Incorporated
by reference to the Registrant’s Registration Statement on Form S-4
(Registration No. 333-123917) filed on April 7,
2005
|
(13) |
Incorporated
by reference to the Registrant’s Form 8-K filed on April 19,
2005
|
(14) |
Incorporated
by reference to the Registrant’s Form 8-K filed on December 16,
2005
|
(15) |
Incorporated
by reference to the Registrant’s Registration Statement on Form S-1/A
filed on April 11, 2006 (Commission File No.
333-130662)
|
(16) |
Incorporated
by reference to the Registrant’s Form 10-Q filed on May 15,
2006
|
(17) |
Incorporated
by reference to the Registrant’s Annual Report on Form 10-K for the fiscal
year ended September 29, 2006
|
(18) |
Incorporated
by reference to the Registrant’s Form 8-K filed on December 13,
2006
|
(19) |
Incorporated
by reference to the Registrant’s Form 10-Q filed on February 12,
2007
|
(20) |
Incorporated
by reference to the Registrant’s Form 8-K filed on August 6,
2007
|
(21) |
Incorporated
by reference to the Registrant’s Form 8-K filed on December 11,
2007
|
(22) |
Incorporated
by reference to the Registrant’s Form 10-Q filed on February 6,
2008
|
(23) |
Incorporated
by reference to the Registrant’s Form 10-K filed on December 15,
2008
|
(24) |
Incorporated
by reference to the Registrant’s Form 8-K filed on February 25,
2009
|